Publications
2025
Scholarly publications
Leung, M. W. Y., van de Garde, E. M. W., Uitdehaag, B. M. J., Souverein, P. C., Klungel, O. H., & Bazelier, M. T. (2025). The Effect of Use of Tricyclic Antidepressants or Serotonin-Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case–Control Study. Pharmacoepidemiology and Drug Safety, 34(11), Article e70260. [DOI] [Portal]
Bots, S. H., Belitser, S., Groenwold, R. H. H., Durán, C. E., Riera-Arnau, J., Schultze, A., Messina, D., Segundo, E., Douglas, I., Carreras, J. J., Garcia-Poza, P., Gini, R., Huerta, C., Martín-Pérez, M., Martin, I., Paoletti, O., Bissacco, C. A., Correcher-Martínez, E., Souverein, P., ... Klungel, O. H. (2025). Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example. American Journal of Epidemiology, 194(1), Article kwae172. [DOI] [Portal]
Schultze, A., Martin, I., Messina, D., Bots, S., Belitser, S., Carreras-Martínez, J. J., Correcher-Martinez, E., Urchueguía-Fornes, A., Martín-Pérez, M., García-Poza, P., Villalobos, F., Pallejà-Millán, M., Bissacco, C. A., Segundo, E., Souverein, P., Riefolo, F., Durán, C. E., Gini, R., Sturkenboom, M., ... Douglas, I. (2025). Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039–3048, (S0264410X2400330X), (10.1016/j.vaccine.2024.03.043)]. Vaccine, 44, 126438. Article 126438. [DOI] [Portal]
2024
Scholarly publications
van Hulten, V., Souverein, P. C., Starup-Linde, J., Viggers, R., Klungel, O. H., Vestergaard, P., Brouwers, M. C. J. G., van den Bergh, J. P., & Driessen, J. H. M. (2024). The association of type 2 diabetes-related characteristics with fracture risk at different sites. Diabetes, Obesity and Metabolism, 26(11), 4887-4896. [DOI] [Portal]
Iversen, D. B., Dunvald, A.-C. D., Ernst, M. T., Abtahi, S., Souverein, P., Klungel, O., Jeppesen, G. B., Nielsen, F., Brøsen, K., Hammer, H. S., Pötz, O., Damkier, P., Järvinen, E., Pottegård, A., & Stage, T. B. (2024). Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users. British Journal of Clinical Pharmacology, 90(12), 3252-3262. [DOI] [Portal]
Schultze, A., Martin, I., Messina, D., Bots, S., Belitser, S., José Carreras-Martínez, J., Correcher-Martinez, E., Urchueguía-Fornes, A., Martín-Pérez, M., García-Poza, P., Villalobos, F., Pallejà-Millán, M., Alberto Bissacco, C., Segundo, E., Souverein, P., Riefolo, F., Durán, C. E., Gini, R., Sturkenboom, M., ... Douglas, I. (2024). A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases. Vaccine, 42(12), 3039-3048. [DOI] [Repository]
Lalmohamed, A., Venekamp, R. P., Bolhuis, A., Souverein, P. C., van de Wijgert, J. H. H. M., Gulliford, M. C., & Hay, A. D. (2024). Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study. The Journal of Infection, 88(4), Article 106135. [DOI] [Repository]
Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J. P., & Vestergaard, P. (2024). Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study. Bone, 180, 1-9. Article 116997. [DOI] [Repository]
Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J., & Vestergaard, P. (2024). Fracture patterns in adult onset type 1 diabetes and associated risk factors - A nationwide cohort study. Bone, 179, 1-10. Article 116977. [DOI] [Repository]
van Veelen, A., Veerman, G. D. M., Verschueren, M. V., Gulikers, J. L., Steendam, C. M. J., Brouns, A. J. W. M., Dursun, S., Paats, M. S., Tjan-Heijnen, V. C. G., van der Leest, C., Dingemans, A. M. C., Mathijssen, R. H. J., van de Garde, E. M. W., Souverein, P., Driessen, J. H. M., Hendriks, L. E. L., van Geel, R. M. J. M., & Croes, S. (2024). Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer. International Journal of Cancer, 154(2), 332-342. [DOI] [Repository]
2023
Scholarly publications
Tsai, D. H.-T., Bell, J. S., Abtahi, S., Baak, B. N., Bazelier, M. T., Brauer, R., Chan, A. Y. L., Chan, E. W., Chen, H., Chui, C. S. L., Cook, S., Crystal, S., Gandhi, P., Hartikainen, S., Ho, F. K., Hsu, S.-T., Ilomäki, J., Kim, J. H., Klungel, O. H., ... Lai, E. C.-C. (2023). Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders. Clinical Epidemiology, 2023(15), 1241-1252. [DOI] [Repository]
la Roi-Teeuw, H. M., van Smeden, M., Geersing, G.-J., Klungel, O. H., Rutten, F. H., Souverein, P. C., & van Doorn, S. (2023). Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study. European Heart Journal Open, 3(6), 1-12. Article oead101. [DOI] [Repository]
Riefolo, F., Castillo-Cano, B., Martín-Pérez, M., Messina, D., Elbers, R., Brink-Kwakkel, D., Villalobos, F., Ingrasciotta, Y., Garcia-Poza, P., Swart-Polinder, K., Souverein, P., Saiz, L. C., Bissacco, C. A., Leache, L., Tari, M., Crisafulli, S., Grimaldi, L., Vaz, T., Gini, R., ... Martín-Merino, E. (2023). Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries. Vaccine, 41(47), 7007-7018. [DOI] [Repository]
Schene, M. R., Wyers, C. E., Driessen, A. M. H., Souverein, P. C., Gemmeke, M., Van Den Bergh, J. P., & Willems, H. C. (2023). Imminent fall risk after fracture. Age and Ageing, 52(10), Article afad201. [DOI] [Repository]
van Hulten, V., Driessen, J. H. M., Starup-Linde, J. K., Al-Mashhadi, Z. K., Viggers, R., Klungel, O. H., Souverein, P. C., Vestergaard, P., Stehouwer, C. D. A., & van den Bergh, J. P. (2023). The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. Diabetes, Obesity & Metabolism, 25(11), 3235-3247. [DOI] [Repository]
Gulikers, J. L., van Veelen, A. J., Driessen, J. H. M., Souverein, P. C., Tjan-Heijnen, V. C. G., Hendriks, L. E. L., van Geel, R. M. J. M., & Croes, S. (2023). Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD. Pharmacoepidemiology and Drug Safety, 32(10), 1161-1177. [DOI] [Repository]
Jansen, M. E., Rigter, T., Fleur, T. M. C., Souverein, P. C., Verschuren, W. M. M., Vijverberg, S. J., Swen, J. J., Rodenburg, W., & Cornel, M. C. (2023). Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users. Genes, 14(2), Article 456. [DOI] [Repository]
Hageman, S. H., Petitjean, C., Pennells, L., Kaptoge, S., Pajouheshnia, R., Tillmann, T., Blaha, M. J., McClelland, R. L., Matsushita, K., Nambi, V., Klungel, O. H., Souverein, P. C., van der Schouw, Y. T., Verschuren, W. M., Lehmann, N., Erbel, R., Jöckel, K.-H., Di Angelantonio, E., Visseren, F. L., & Dorresteijn, J. A. (2023). Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2. European Journal of Preventive Cardiology, 30(15), 1705-1714. [DOI] [Repository]
Abtahi, S., Pajouheshnia, R., Durán, C. E., Riera-Arnau, J., Gamba, M., Alsina, E., Hoxhaj, V., Andersen, M., Bartolini, C., Kristiansen, S. B., Brown, J., Hallgreen, C. E., Garcia-Poza, P., Gardarsdottir, H., Gini, R., Girardi, A., Holthuis, E., Huerta, C., Ibánez, L., ... Klungel, O. (2023). Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study. Drug Safety, 46(7), 689-702. [DOI] [Repository]
Samukange, W. T., Lu, T.-A., Souverein, P. C., Gardarsdottir, H., & Mantel-Teeuwisse, A. K. (2023). Suspected adverse reactions reported for blood, blood components, and blood products in VigiBase. Transfusion, 63(5), 982-992. [DOI] [Repository]
Hunt, N. B., Pajouheshnia, R., Salih, A., van Doorn, S., Souverein, P. C., Bazelier, M. T., Klungel, O. H., & Gardarsdottir, H. (2023). Prescribing of low-dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the United Kingdom and the Netherlands. British Journal of Clinical Pharmacology, 89(7), 2263-2271. [DOI] [Repository]
Willame, C., Dodd, C., Durán, C. E., Elbers, R., Gini, R., Bartolini, C., Paoletti, O., Wang, L., Ehrenstein, V., Kahlert, J., Haug, U., Schink, T., Diez-Domingo, J., Mira-Iglesias, A., Carreras, J. J., Vergara-Hernández, C., Giaquinto, C., Barbieri, E., Stona, L., ... Sturkenboom, M. (2023). Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study. Vaccine, 41(1), 251-262. [DOI] [Repository]
Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., Van Den Bergh, J. P., & Boonen, A. (2023). Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: A population-based cohort study' by Gong and Zhang and Lin et al. Annals of the Rheumatic Diseases, 82(6), Article e143. [DOI] [Repository]
Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., van den Bergh, J. P., van Staa, T. P., Boonen, A., & de Vries, F. (2023). Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng. Annals of the Rheumatic Diseases, 82(4), Article e219856. [DOI] [Repository]
2022
Scholarly publications
Eroglu, T. E., Coronel, R., Zuurbier, C. J., Blom, M., de Boer, A., & Souverein, P. C. (2022). Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus. European heart journal. Cardiovascular pharmacotherapy, 9(1), 18-25. [DOI] [Repository]
Bots, S. H., Riera-Arnau, J., Belitser, S. V., Messina, D., Aragón, M., Alsina, E., Douglas, I. J., Durán, C. E., García-Poza, P., Gini, R., Herings, R. M. C., Huerta, C., Sisay, M. M., Martín-Pérez, M., Martin, I., Overbeek, J. A., Paoletti, O., Pallejà-Millán, M., Schultze, A., ... Sturkenboom, M. C. J. M. (2022). Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries. Frontiers in Pharmacology, 13, 1-12. Article 1038043. [DOI] [Repository]
Kemp-Casey, A., Mintzes, B., Morrow, R. L., Dormuth, C. R., Souverein, P. C., & Roughead, E. E. (2022). Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: An interrupted time series study. Pharmacoepidemiology and Drug Safety, 31(10), 1039-1045. [DOI] [Repository]
Sarodnik, C., Rasmussen, N. H., Bours, S. P. G., Schaper, N. C., Vestergaard, P., Souverein, P. C., Jensen, M. H., Driessen, J. H. M., & van den Bergh, J. P. W. (2022). The incidence of fractures at various sites in newly treated patients with type 2 diabetes mellitus. Bone Reports, 17, 1-8. Article 101614. [DOI] [Repository]
van den Dries, C. J., Pajouheshnia, R., van den Ham, H. A., Souverein, P., Moons, K. G. M., Hoes, A. W., Geersing, G. J., & van Doorn, S. (2022). Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. British Journal of Clinical Pharmacology, 89(2), 751-761. [DOI] [Repository]
ESCAPE-NET Investigators (2022). Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study. PLoS One, 17(6), 1-12. Article e0267016. [DOI] [Repository]
Morrow, R. L., Mintzes, B., Souverein, P. C., Hallgreen, C. E., Ahmed, B., Roughead, E. E., De Bruin, M. L., Kristiansen, S. B., Lexchin, J., Kemp-Casey, A., Sketris, I., Mangin, D., Pearson, S.-A., Puil, L., Lopert, R., Bero, L., Gnjidic, D., Sarpatwari, A., & Dormuth, C. R. (2022). Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study. Drug Safety, 45(6), 623-638. [DOI] [Repository]
Leung, M. W., Bazelier, M. T., Souverein, P. C., Uitdehaag, B. M., Klungel, O. H., Leufkens, H. G., & Pajouheshnia, R. (2022). Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum. Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1808-1818. [DOI] [Repository]
van Veelen, A., Abtahi, S., Souverein, P., Driessen, J. H. M., Klungel, O. H., Dingemans, A.-M. C., van Geel, R., de Vries, F., & Croes, S. (2022). Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. Cancer Epidemiology, 78, 1-8. Article 102149. [DOI] [Repository]
van Sloten, T. T., Souverein, P. C., Stehouwer, C. DA., & Driessen, J. H. (2022). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension. Journal of Psychopharmacology, 36(5), 594-603. [DOI] [Repository]
Camacho-Arteaga, L. F., Gardarsdottir, H., Ibañez, L., Souverein, P. C., van Dijk, L., Hek, K., Vidal, X., Ballarín, E., & Sabaté, M. (2022). Indications related to antidepressant prescribing in the Nivel-PCD database and the SIDIAP database. Journal of Affective Disorders, 303, 131-137. [DOI] [Repository]
Morrow, R. L., Mintzes, B., Souverein, P. C., De Bruin, M. L., Roughead, E. E., Lexchin, J., Kemp-Casey, A., Puil, L., Sketris, I., Mangin, D., Hallgreen, C. E., Pearson, S.-A., Lopert, R., Bero, L., Ofori-Asenso, R., Gnjidic, D., Sarpatwari, A., Perry, L. T., & Dormuth, C. R. (2022). Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ Quality & Safety, 31(3), 179-190. Article 013910. [DOI] [Repository]
De Wit, L. E., Wilting, I., Souverein, P. C., van der Pol, P., & Egberts, T. C. G. (2022). Impulse control disorders associated with dopaminergic drugs: A disproportionality analysis using vigibase. European Neuropsychopharmacology, 58, 30-38. [DOI] [Repository]
Rasmussen, N. H., Sarodnik, C., Bours, S. P. G., Schaper, N. C., Souverein, P. C., Jensen, M. H., Driessen, J. H. M., van den Bergh, J. P. W., & Vestergaard, P. (2022). The pattern of incident fractures according to fracture site in people with T1D. Osteoporosis International, 33(3), 599–610. [DOI] [Repository]
ESCAPE-NET Investigators (2022). Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40,000-cases across two countries. British Journal of Clinical Pharmacology, 88(5), 2256-2266. [DOI] [Repository]
Eroglu, T. E., Blom, M. T., Souverein, P. C., de Boer, A., & Tan, H. L. (2022). Multiple categories of non-cardiac QT-prolonging drugs are associated with increased risk of out-of-hospital cardiac arrest: real-world data from a population-based study. Europace, 24(4), 630–638. [DOI] [Repository]
for the ESCAPE-NET Investigators (2022). Out-of-hospital cardiac arrest and differential risk of cardiac and non-cardiac QT-prolonging drugs in 37 000 cases. British Journal of Clinical Pharmacology, 88(2), 820-829. [DOI] [Repository]
Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., van den Bergh, J. P., van Staa, T. P., Boonen, A., & de Vries, F. (2022). Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink. Rheumatology (Oxford, England), 61(4), 1448–1458. [DOI] [Repository]
2021
Scholarly publications
Morrow, R. L., Mintzes, B., Souverein, P. C., Bruin, M. L. D., Roughead, E. E., Lexchin, J., Kemp-Casey, A., Puil, L., Sketris, I., Mangin, D., CE, H., Pearson, S.-A., Lopert, R., Bero, L., Ofori-Asenso, R., Gnjidic, D., Sarpatwari, A., & Dormuth, C. R. (2021). Influence of drug safety advisories on drug utilization: An international interrupted time series and meta-analysis study. 33-34. Abstract from 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Sabaté, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Grave, B., Huerta, C., Martin-Merino, E., Montero, D., Leon-Muñoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjær, M., Andersen, M., De Bruin, M. L., Souverein, P., Klungel, O. H., ... Ibáñez, L. (2021). Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015). Frontiers in Pharmacology, 12, Article 682890. [DOI] [Repository]
van den Ham, H. A., Souverein, P. C., Klungel, O. H., Platt, R. W., Ernst, P., Dell'Aniello, S., Schmiedl, S., Grave, B., Rottenkolber, M., Huerta, C., Martín Merino, E., León-Muñoz, L. M., Montero, D., Andersen, M., Aakjær, M., De Bruin, M. L., & Gardarsdottir, H. (2021). Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies. Pharmacoepidemiology and Drug Safety, 30(10), 1339-1352. [DOI] [Repository]
Eroglu, T. E., Jia, L., Blom, M. T., Verkerk, A. O., Devalla, H. D., Boink, G. J. J., Souverein, P. C., de Boer, A., & Tan, H. L. (2021). Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest: Real-world data from a population-based study. British Journal of Clinical Pharmacology, 87(9), 3588-3598. [DOI] [Repository]
Zhang, Y., Souverein, P. C., & Gardarsdottir, H. (2021). DOAC drug interactions and risk of major bleeding. Drug and Therapeutics Bulletin, 59(5), 70. [DOI] [Repository]
Abedian, S., Abbasi, A., de Boer, A., Stricker, B. H., Bakker, S. J. L., van der Harst, P., Sedaghat, S., Darvishian, M., Ikram, M. A., Navis, G., Dehghan, A., Pen, I., Stolk, R. P., Snieder, H., Klungel, O. H., Souverein, P., & Alizadeh, B. Z. (2021). Effect of metabolic genetic variants on long-term disease comorbidity in patients with type 2 diabetes. Scientific Reports, 11(1), Article 2794. [DOI] [Repository]
Lefeber, G. J., Knol, W., Souverein, P. C., Bouvy, M. L., de Boer, A., & Koek, H. L. (2021). Statins After Ischemic Stroke in the Oldest: A Cohort Study Using the Clinical Practice Research Datalink Database. Stroke, 52(4), 1244-1252. [DOI] [Repository]
Hempenius, M., Groenwold, R. H. H., Souverein, P. C., de Boer, A., Klungel, O. H., & Gardarsdottir, H. (2021). Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants. British Journal of Clinical Pharmacology, 87(9), 3508-3517. [DOI] [Repository]
Rustem Gulluoglu, F., Souverein, P. C., van den Ham, H. A., de Boer, A., & Komen, J. (2021). Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: a retrospective cohort study. Pharmacoepidemiology and Drug Safety, 30(10), 1293-1320. [DOI] [Repository]
Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., van den Bergh, J. P., van Staa, T. P., Boonen, A., & de Vries, F. (2021). Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study. Annals of the Rheumatic Diseases, 80(4), 423–431. [DOI] [Repository]
PE, PV consortium H. Gardarsdottir (2021). Prescribers' compliance with Summary of Product Characteristics of dabigatran, rivaroxaban and apixaban - a European comparative drug utilization study. Basic & Clinical Pharmacology & Toxicology, 128(3), 440-454. [DOI] [Repository]
Souverein, P. C., van den Ham, H. A., Huerta, C., Merino, E. M., Montero, D., León-Muñoz, L. M., Schmiedl, S., Heeke, A., Rottenkolber, M., Andersen, M., Aakjaer, M., De Bruin, M. L., Klungel, O. H., & Gardarsdottir, H. (2021). Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation. British Journal of Clinical Pharmacology, 87(3), 988-1000. [DOI] [Repository]
2020
Scholarly publications
van den Dries, C. J., van Doorn, S., Souverein, P., Pajouheshnia, R., Moons, K. G. M., Hoes, A. W., Geersing, G.-J., & van den Ham, H. A. (2020). The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation. TH Open: Companion Journal to Thrombosis and Haemostasis, 4(4), e417-e426. [DOI] [Repository]
Driessen, J. H. M., Sarodnik, C., Rasmussen, N. H., Bours, S. P. G., Schaper, N. C., Vestergaard, P., Souverein, P. C., Jensen, M., de Vries, F., & van den Bergh, J. P. W. (2020). The pattern of incident fractures in patients with newly diagnosed type 2 diabetes mellitus. Pharmacoepidemiology and Drug Safety, 29(S3), 65-65. Article 4363. [DOI]
de Vries, F., Driessen, A., Burden, A., Souverein, P., van Staa, T., van den Bergh, J., & Abtahi, S. (2020). The effect of low-dose oral glucocorticoid therapy on osteoporotic fracture risk in patients with rheumatoid arthritis. Pharmacoepidemiology and Drug Safety, 29, 284-285.
van Veelen, A., Abtahi, S., Souverein, P., Driessen, J. H. M., Klungel, O. H., Dingemans, A.-M., van Geel, R., de Vries, F., & Croes, S. (2020). Characteristics and study eligibility of British lung cancer patients for clinical trials evaluating targeted therapies (TTS) or immune checkpoint inhibitors (ICIS). Pharmacoepidemiology and Drug Safety, 29(suppl. 3), 46. Article 4663. [DOI] [Repository]
Hulleman, M., Salcido, D. D., Menegazzi, J. J., Souverein, P. C., Tan, H. L., Blom, M. T., & Koster, R. W. (2020). Ventricular fibrillation waveform characteristics in out-of-hospital cardiac arrest and cardiovascular medication use. Resuscitation, 151, 173-180. [DOI] [Repository]
Beex-Oosterhuis, M. M., Samb, A., Heerdink, E. R., Souverein, P. C., Van Gool, A. R., Meyboom, R. H. B., & van Marum, R. J. (2020). Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data. Pharmacoepidemiology and Drug Safety, 29(6), 725-735. [DOI] [Repository]
Barcella, C. A., Eroglu, T. E., Hulleman, M., Granfeldt, A., Souverein, P. C., Mohr, G. H., Koster, R. W., Wissenberg, M., de Boer, A., Torp-Pedersen, C., Folke, F., Blom, M. T., Gislason, G. H., & Tan, H. L. (2020). Association of beta-blockers and first-registered heart rhythm in out-of-hospital cardiac arrest: real-world data from population-based cohorts across two European countries. Europace, 22(8), 1206–1215. Article euaa124. [DOI] [Repository]
Man, W. H., Wilting, I., Souverein, P., Meyboom, R., Egberts, T., & Heerdink, E. R. (2020). Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase. Journal of Clinical Psychopharmacology, 40(3), 283-286. [DOI] [Repository]
Aguiar, J. P., Alves da Costa, F., Egberts, T., Leufkens, H., & Souverein, P. (2020). The association between receptor binding affinity and metabolic side effect profile of antipsychotics and major cardio- and cerebrovascular events: A case/non-case study using VigiBase. European Neuropsychopharmacology, 35, 30-38. [DOI] [Repository]
Althunian, T. A., de Boer, A., Groenwold, R. H. H., Rengerink, K. O., Souverein, P. C., & Klungel, O. H. (2020). Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study. Pharmacoepidemiology and Drug Safety, 29(10), 1263-1272. [DOI] [Repository]
de Bruin, I. J. A., Wyers, C. E., Souverein, P. C., van Staa, T. P., Geusens, P. P. M. M., van den Bergh, J. P. W., de Vries, F., & Driessen, J. H. M. (2020). The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK. Osteoporosis International, 31(8), 1487-1497. [DOI] [Repository]
Zhang, Y., Souverein, P. C., Gardarsdottir, H., van den Ham, H. A., Maitland-van der Zee, A. H., & de Boer, A. (2020). Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: a population-based nested case-control study. British Journal of Clinical Pharmacology, 86(6), 1150-1164. [DOI] [Repository]
Lefeber, G. J., Koek, H. L., Souverein, P. C., Bouvy, M. L., de Boer, A., & Knol, W. (2020). Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database. Journal of the American Geriatrics Society, 68(2), 329-336. [DOI] [Repository]
Respiratory Effectiveness Group's Adherence Working Group (2020). The Relationship Between Real-World Inhaled Corticosteroid Adherence and Asthma Outcomes: A Multilevel Approach. Journal of Allergy and Clinical Immunology: In Practice, 8(2), 626-634. [DOI] [Repository]
Eroglu, T. E., Mohr, G. H., Blom, M. T., Verkerk, A. O., Souverein, P. C., Torp-Pedersen, C., Folke, F., Wissenberg, M., van den Brink, L., Davis, R. P., de Boer, A., Gislason, G. H., & Tan, H. L. (2020). Differential effects on out-of-hospital cardiac arrest of dihydropyridines: real-world data from population-based cohorts across two European countries. European heart journal. Cardiovascular pharmacotherapy, 6, 347-355. [DOI] [Repository]
2019
Scholarly publications
Souverein, P. C., den Ham, H. A. V., Huerta, C., Merino, E. M., Montero, D., Leon-Munoz, L. M., Schmiedl, S., Rottenkolber, M., Andersen, M., Aakjaer, M., Bruin, M. L. D., Klungel, O. H., & Gardarsdottir, H. (2019). Risk of major bleeding associated with the use of direct oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation: A European multi-country population-based cohort study.
van den Ham, H., Souverein, P., Klungel, O., Platt, R., Ernst, P., Dell'Aniello, S., Schmiedl, S., Grave, B., Rottenkolber, M., Huerta, C., Merino, E. M., Leon-Munoz, L., Montero, D., Andersen, M., Aakjaer, M., Bruin, M. L. D., & Gardarsdottir, H. (2019). Risk of major bleeding associated with the use of individual direct oral anticoagulants compared to vitamin K antagonists in patients with non-valvular atrial fibrillation: A metaanalysis of results from multiple population based cohort studies using a common protocol in Europe and Canada. Pharmacoepidemiology and Drug Safety, 28(S2). [DOI]
Souverein, P. C., Van Den Ham, H. A., Huerta, C., Merino, E. M., Montero, D., León-Muñoz, L. M., Schmiedl, S., Rottenkolber, M., Andersen, M., Aakjær, M., De Bruin, M. L., Klungel, O. H., & Gardarsdottir, H. (2019). Risk of major bleeding associated with the use of direct oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation: A European multicountry population-based cohort study. Pharmacoepidemiology and Drug Safety, 28(S2), 553-553. [DOI]
Van Den Ham, H., Souverein, P., Klungel, O., Platt, R., Ernst, P., Dell'Aniello, S., Schmiedl, S., Grave, B., Rottenkolber, M., Huerta, C., Merino, E. M., León-Muñoz, L., Montero, D., Andersen, M., Aakjær, M., De Bruin, M., & Gardarsdottir, H. (2019). Risk of major bleeding associated with the use of individual direct oral anticoagulants compared to vitamin K antagonists in patients with non-valvular atrial fibrillation: A metaanalysis of results from multiple population based cohort studies using a common protocol in Europe and Canada. Pharmacoepidemiology and Drug Safety, 28(S2), 410-411. [DOI]
Rottenkolber, M., Schmiedl, S., Ibanez, L., Sabaté, M., Ballarín, E., Vidal, X., Leon-Munoz, L. M., Huerta, C., Martin Merino, E., Montero, D., Gasse, C., Andersen, M., Aakjær, M., De Bruin, M. L., Gerlach, R., Tauscher, M., Souverein, P. C., Van Den Ham, R., Klungel, O., & Gardarsdottir, H. (2019). Prescribers' compliance with SmPC recommendations for dabigatran, rivaroxaban, and Apixaban: A European comparative drug utilization study. Pharmacoepidemiology and Drug Safety, 28(S2), 148-149. [DOI]
Ibanez, L., Sabaté, M., Vidal, X., Ballarín, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., Merino, E. M., Montero, D., Leon-Muñoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjaer, M., Andersen, M., De Bruin, M. L., Groenwold, R., ... Gardarsdottir, H. (2019). Incidence of direct oral anticoagulation use for non valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-national drug utilization study. Pharmacoepidemiology and Drug Safety, 28(S2), 397. [DOI]
Sabaté Gallego, M., Ibáñez Mora, L., Vidal Guitart, X., Ballarin Alins, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., Martin Merino, E., Montero, D., León-Muñoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjaer, M., Andersen, M., De Briun, M., Groenwold, R., ... Gardarsdottir, H. (2019). Adherence to direct oral anticoagulants in patients with non-valvular atrial fibrillation cross-national comparison in six european countries. European Journal of Clinical Pharmacology, 75, 27-28. [DOI]
Althunian, T. A. I., De Boer, A., Groenwold, R. H. H., Rengerink, K. O., Souverein, P. C., & Klungel, O. H. (2019). Replication of rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation in a cohort study using electronic primary care database. Pharmacoepidemiology and Drug Safety, 28(S2), 57-58. [DOI] [Repository]
Camacho Arteaga, L. F., Gardarsdottir, H., Souverein, P., Van Dijk, L., Sabaté, M., Vidal, X., Ballarín, E., & Ibañez, L. (2019). Indications related to antidepressant drug prescribing in the elderly population during 2010-2015 in two primary care databases: the Netherlands and Catalonia (Spain). European Journal of Clinical Pharmacology, 75(suppl 1), 49-50. [DOI]
Ibáñez, L., Sabaté, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., Martin Merino, E., Montero, D., Leon-Muñoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjær, M., Andersen, M., De Bruin, M. L., Groenwold, R., ... Gardarsdottir, H. (2019). Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross-national drug utilization study. British Journal of Clinical Pharmacology, 85(11), 2524-2539. [DOI] [Repository]
Bakhriansyah, M., Souverein, P. C., van den Hoogen, M. W. F., de Boer, A., & Klungel, O. H. (2019). Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users. Clinical journal of the American Society of Nephrology : CJASN, 14(9), 1355-1362. [DOI] [Repository]
Minnema, L. A., Giezen, T. J., Souverein, P. C., Egberts, T. C. G., Leufkens, H. G. M., & Gardarsdottir, H. (2019). Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study. Drug Safety, 42(7), 887-895. [DOI] [Repository]
Eroglu, T. E., Mohr, G. H., Blom, M. T., Torp-Pedersen, C., Souverein, P. C., De Boer, A., Gislason, G. H., & Tan, H. L. (2019). High-dose nifedipine use is associated with increased risk of out-of-hospital cardiac arrest: Multi-country case-control study. Europace, 21(suppl 2), Article P568. https://esc365.escardio.org/Congress/EHRA-2019/Young-EP-poster-session-Young-meets-Experienced/188365-high-dose-nifedipine-use-is-associated-with-increased-risk-of-out-of-hospital-cardiac-arrest-multi-country-case-control-study [Repository]
Minjon, L., van den Ban, E., de Jong, E., Souverein, P. C., Egberts, T. C. G., & Heerdink, E. R. (2019). Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics. Journal of Child and Adolescent Psychopharmacology, 29(2), 124-132. [DOI] [Repository]
Bakhriansyah, M., Meyboom, R. H. B., Souverein, P. C., de Boer, A., & Klungel, O. H. (2019). Cyclooxygenase selectivity and chemical groups of non-steroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/non-case study in VigiBase. Fundamental and Clinical Pharmacology, 33(5), 589-600. [DOI] [Repository]
Bakhriansyah, M., Souverein, P. C., de Boer, A., & Klungel, O. H. (2019). Risk of myocardial infarction associated with non-steroidal anti-inflammatory drugs: Impact of additional confounding control for variables collected from self-reported data. Journal of Clinical Pharmacy and Therapeutics, 44(4), 623-631. [DOI] [Repository]
Nederlof, M., Egberts, T. C. G., van Londen, L., de Rotte, M. C. F. J., Souverein, P. C., Herings, R. C. M., & Heerdink, E. R. (2019). Compliance with the guidelines for laboratory monitoring of patients treated with lithium: a retrospective follow-up study among ambulatory patients in the Netherlands. Bipolar Disorders, 21(5), 419-427. [DOI] [Repository]
Tran-Duy, A., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., Hoes, A. W., de Vries, F., & de Boer, A. (2019). Use of proton pump inhibitor and risk of iron deficiency: a population-based case-control study. Journal of Internal Medicine, 285(2), 205-214. [DOI] [Repository]
Bakhriansyah, M., Souverein, P. C., Klungel, O. H., de Boer, A., Blom, M. T., & Tan, H. L. (2019). Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case-control study. Europace, 21(1), 99-105. [DOI] [Repository]
2018
Scholarly publications
De Bruin, I. J., Wyers, C. E., Souverein, P. C., Van Staa, T. P., Geusens, P. P., Van den Bergh, J. P., De Vries, F., & Driessen, J. H. (2018). Increased mortality risk, but no increased subsequent fracture risk following hip fracture in elderly patients with chronic kidney disease. Journal of Bone and Mineral Research, 33, 269-270.
Marees, A. T., Hammerschlag, A. R., Bastarache, L., de Kluiver, H., Vorspan, F., van den Brink, W., Smit, D. J., Denys, D., Gamazon, E. R., Li-Gao, R., Breetvelt, E. J., de Groot, M. C. H., Galesloot, T. E., Vermeulen, S. H., Poppelaars, J. L., Souverein, P. C., Keeman, R., de Mutsert, R., Noordam, R., ... Derks, E. M. (2018). Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use. Drug and Alcohol Dependence, 188, 94-101. [DOI] [Repository]
van Strien, A. M., Souverein, P. C., Keijsers, C. J. P. W., Heerdink, E. R., Derijks, H. J., & van Marum, R. J. (2018). Association Between Urinary Tract Infections and Antipsychotic Drug Use in Older Adults. Journal of Clinical Psychopharmacology, 38(4), 296-301. [DOI] [Repository]
Minnema, L., Giezen, T., Souverein, P., Egberts, T., Leufkens, B., & Gardarsdottir, H. (2018). Exploring the association between monoclonal antibodies and depression and suicidal ideation and behavior: A vigibase study. Drug Safety, 41(11), 1197-1198. [DOI]
Klungel, O., Bakhriansyah, M., Meijboom, R., Souverein, P., & De Boer, A. (2018). Cox selectivity and chemical subgroup of non-steroidal anti-inflammatory drugs and frequency of spontaneous reporting of hypersensitivity reactions. Drug Safety, 41(11), 1166. [DOI] [Repository]
Minnema, L. A., Giezen, T. J., Souverein, P. C., Egberts, T. C. G., Leufkens, H. G. M., & Gardarsdottir, H. (2018). Exploring the association between monoclonal antibodies and depression and suicidal ideation and behaviour: A VigiBase study. Pharmacoepidemiology and Drug Safety, 27, 50. [DOI]
Zhang, Y., De Boer, A., Gardarsdottir, H., Van Den Ham, H. A., Maitland-Van Der Zee, A. H., & Souverein, P. C. (2018). Concurrent use of DOACs and pharmacodynamic interacting drugs is associated with an increased risk of major bleeding compared with patients using DOACs alone: Nested case-control study in UK CPRD. Pharmacoepidemiology and Drug Safety, 27, 465-466. [DOI] [Repository]
Bakhriansyah, M., Meyboom, R. H. B., Souverein, P. C., De Boer, A., & Klungel, O. H. (2018). Cyclooxygenase selectivity and chemical subgroup of non-steroidal anti-inflammatory drugs and frequency of spontaneous reporting of hypersensitivity reactions: A case/non-case study in Vigibase. Pharmacoepidemiology and Drug Safety, 27(S2), 264. [DOI] [Repository]
Mahmoudpour, S. H., Asselbergs, F. W., Souverein, P. C., de Boer, A., & Maitland-van der Zee, A. H. (2018). Prescription Patterns of Angiotensin-Converting Enzyme Inhibitors for Various Indications: A UK Population-based Study. British Journal of Clinical Pharmacology, 84(10), 2365-2372. [DOI] [Repository]
Scheepers, L. E. J. M., Burden, A. M., Arts, I. C. W., Spaetgens, B., Souverein, P., de Vries, F., & Boonen, A. (2018). Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Rheumatology (Oxford, England), 57(9). [DOI] [Repository]
Keyany, A., Nielen, J. T. H., Souverein, P. C., de Vries, F., & van den Bemt, B. (2018). Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study. Diabetes Research and Clinical Practice, 139, 100-106. [DOI] [Repository]
Ahmadizar, F., Souverein, P., de Boer, A., & Maitland-van der Zee, A. H. (2018). Under-treatment of hypertension and hypercholesterolemia in children and adolescents with type 1 diabetes- Long term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use. British Journal of Clinical Pharmacology, 84(4), 776-785. [DOI] [Repository]
Fazeli Farsani, S., Abdullah-Koolmees, H., Souverein, P. C., de Boer, A., & Mantel-Teeuwisse, A. K. (2018). Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study. Pediatric Diabetes, 19(1), 121-128. [DOI] [Repository]
2017
Scholarly publications
de Vries, F., Rohde, G. G. U., Braeken, D. C. W., van Staa, T. P., Souverein, P. C., Wouters, E. F. M., & Franssen, F. M. E. (2017). Upregulated pneumococcal adhesion molecule (platelet-activating factor receptor) may predispose COPD patients to community-acquired pneumonia: Author's Reply. International Journal of COPD, 12, 3113-3113. [DOI] [Portal]
van Strien, A. M., Souverein, P. C., Keijsers, C. K. J. P. W., Heerdink, E. R., Derijks, H. J. J., & Van Marum, R. J. (2017). Antipsychotic drug use associated with urinary tract infections in older women. Maturitas, 98, 46-50. [DOI] [Repository]
van den Bogert, C. A., Souverein, P. C., Brekelmans, C. T. M., Janssen, S. W. J., Koëter, G. H., Leufkens, H. G. M., & Bouter, L. M. (2017). Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands. Journal of Clinical Epidemiology, 88, 140-147. [DOI] [Repository]
van den Bogert, C. A., Souverein, P. C., Brekelmans, C. T. M., Janssen, S. W. J., Koëter, G. H., Leufkens, H. G. M., & Bouter, L. M. (2017). Primary endpoint discrepancies were found in one in ten clinical drug trials. Results of an inception cohort study. Journal of Clinical Epidemiology, 89, 199-208. [DOI] [Repository]
Hulleman, M., Salcido, D. D., Menegazzi, J. J., Souverein, P. C., Tan, H. L., Blom, M. T., & Koster, R. W. (2017). Predictive value of amplitude spectrum area of ventricular fibrillation waveform in patients with acute or previous myocardial infarction in out-of-hospital cardiac arrest. Resuscitation, 120, 125-131. [DOI] [Repository]
Bakhriansyah, M., Souverein, P., De Boer, A., & Klungel, O. H. (2017). The risk of acute myocardial infarction associated with non-steroidal anti-inflammatory drugs users: Impact of additional confounding control for variables collected from self-reported data. Pharmacoepidemiology and Drug Safety, 26(S2), 89. [DOI] [Repository]
Maagdenberg, H., Souverein, P. C., Bierings, M. B., De Boer, A., & Maitland-Van Der Zee, A. H. (2017). Incidence of bleeding and thrombotic events in non-institutionalized paediatric patients using warfarin in the united kingdom. Pharmacoepidemiology and Drug Safety, 26(S2), 273-274. [DOI] [Repository]
Rahman, N. A. B., Yasmina, A., De Boer, A., Deneer, V. H. M., Souverein, P. C., & Klungel, O. H. (2017). Patterns of antiplatelet therapy in patients with ischaemic stroke or transient ischaemic attack. Pharmacoepidemiology and Drug Safety, 26, 495. [DOI] [Repository]
Alharbi, F. F., Kholod, A. A. V., Souverein, P. C., Meijboom, R., de Groot, M. C. H., de Boer, A., & Klungel, O. H. (2017). The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase. Fundamental and Clinical Pharmacology, 31(6), 676-684. [DOI] [Repository]
de Vries, F., Rohde, G. G. U., Braeken, D. C. W., van Staa, T. P., Souverein, P. C., Wouters, E. F. M., & Franssen, F. M. E. (2017). Authors’ reply. International Journal of COPD, 12, 3113.
Braeken, D. C. W., Rohde, G. G. U., Franssen, F. M. E., Driessen, J. H. M., van Staa, T. P., Souverein, P. C., Wouters, E. F. M., & de Vries, F. (2017). Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: A population-based cohort study in the United Kingdom. International Journal of COPD, 12, 2425-2432. [DOI] [Repository]
Sagwa, E. L., Souverein, P. C., Ribeiro, I., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2017). Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment. Pharmacoepidemiology and Drug Safety, 26(1), 1-8. [DOI] [Repository]
Alharbi, F. F., Souverein, P. C., de Groot, M. C. H., Blom, M. T., de Boer, A., Klungel, O. H., & Tan, H. L. (2017). The Impact of Serum Potassium-Influencing Antihypertensive Drugs on the Risk of Out-of-Hospital Cardiac Arrest: A Case Control Study. British Journal of Clinical Pharmacology, 83(11), 2541-2548. [DOI] [Repository]
Spaetgens, B., de Vries, F., Driessen, J. H. M., Leufkens, H. G., Souverein, P. C., Boonen, A., van der Meer, J. W. M., & Joosten, L. A. B. (2017). Risk of infections in patients with gout: a population-based cohort study. Scientific Reports, 7(1), Article 1429. [DOI] [Repository]
Bakhriansyah, M., Souverein, P. C., de Boer, A., & Klungel, O. H. (2017). Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study. Pharmacoepidemiology and Drug Safety, 26(10), 1141-1148. [DOI] [Repository]
Mahmoudpour, S. H., Veluchamy, A., Siddiqui, M. K., Asselbergs, F. W., Souverein, P. C., De Keyser, C. E., Hofman, A., Lang, C. C., Doney, A. S. F., Stricker, B. H., De Boer, A., Maitland-Van Der Zee, A. H., & Palmer, C. N. A. (2017). Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors. Pharmacogenetics and Genomics, 27(3), 112-119. [DOI] [Repository]
Stolk, L. M., de Vries, F., Ebbelaar, C., de Boer, A., Schalekamp, T., Souverein, P., Ten Cate-Hoek, A., & Burden, A. M. (2017). Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants. British Journal of Clinical Pharmacology, 83(8), 1835-1843. [DOI] [Repository]
Alharbi, F. F., Souverein, P. C., de Groot, M. C., Maitland-van der Zee, A. H., de Boer, A., & Klungel, O. H. (2017). Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case-control study. Journal of Human Hypertension, 31, 537–544. [DOI] [Repository]
Souverein, P. C., Koster, E. S., Colice, G., van Ganse, E., Chisholm, A., Price, D., & Dima, A. L. (2017). Inhaled Corticosteroid Adherence Patterns in a Longitudinal Asthma Cohort. Journal of Allergy and Clinical Immunology: In Practice, 5(2), 448-456. [DOI] [Repository]
Yasmina, A., de Boer, A., Deneer, V. H. M., Souverein, P. C., & Klungel, O. H. (2017). Patterns of antiplatelet drug use after a first myocardial infarction during a 10-years period. British Journal of Clinical Pharmacology, 83(3), 632-641. [DOI] [Repository]
Other output
Yasmina, A., De Boer, A., Deneer, V. H. M., Ten Berg, J. M., Groenwold, R. H. H., Souverein, P. C., & Klungel, O. H. (2017). Comparative effectiveness and safety of antiplatelet drug regimens as secondary prevention after ischemic stroke or transient ischemic attack. 490-491. Abstract from 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management. [DOI]
2016
Scholarly publications
Braeken, D., Rohde, G., Franssen, F., Driessen, J., van Staa, T., Souverein, P., Wouters, E., & de Vries, F. (2016). Risk of CAP in COPD stratified by smoking status: A population-based cohort study in the UK. European Respiratory Journal, 48. [DOI]
Vasbinder, E. C., Belitser, S., Souverein, P. C., van Dijk, L., Vulto, A. G., & van den Bemt, P. M. (2016). Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children. Patient Preference and Adherence, 10, 531-538. [DOI] [Repository]
van den Bogert, C. A., Souverein, P. C., Brekelmans, C. T. M., Janssen, S. W. J., Koëter, G. H., Leufkens, H. G. M., & Bouter, L. M. (2016). Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials. PLoS One, 11(12), 1-13. Article e0167709. [DOI] [Repository]
Mahmoud Pour, S. H., Siddiqui, M. K., Veluchamy, A., Asselbergs, F. W., Souverein, P. C., De Keyser, C. E., Hofman, A., Stricker, B. H., De Boer, A., Maitland-Van Der Zee, A.-H., & Palmer, C. N. A. (2016). Meta-analysis of the Genome Wide Association Studies (GWAS) on the intolerance of Angiotensin Converting Enzyme Inhibitors (ACEIs). Pharmacoepidemiology and Drug Safety, 25, 383. [DOI] [Repository]
Alharbi, F. F., Kholod, A. A. V., Souverein, P. C., Meyboom, R. H., de Groot, M., De Boer, A., & Klungel, O. H. (2016). A novel approach to study the impact of ethnicity on reporting of cough/angioedema with RAS inhibitors in VigiBase. Pharmacoepidemiology and Drug Safety, 25(S3), 443-44. Article 763. [DOI] [Repository]
Alharbi, F. F., Kholod, A. A. V., Souverein, P. C., Meyboom, R. H., de Groot, M., De Boer, A., & Klungel, O. H. (2016). The impact of age and gender on reporting of cough and angioedema with RAS inhibitors: A case/non-case in VigiBase. Pharmacoepidemiology and Drug Safety, 25, 442. Article 762. [DOI] [Repository]
Mahmoud Pour, S. H., Baranova, E. V., Souverein, P. C., Asselbergs, F. W., de Boer, A., Maitland-van der Zee, A. H., & PREDICTION-ADR Consortium (2016). Determinants of angiotensin converting enzyme-inhibitor (ACEI) intolerance and angioedema in the UK clinical practice research datalink. British Journal of Clinical Pharmacology, 82(6), 1647-1659. [DOI] [Repository]
Klungel, O. H., Kurz, X., de Groot, M. C. H., Schlienger, R. G., Tcherny-Lessenot, S., Grimaldi, L., Ibáñez, L., Groenwold, R. H. H., Reynolds, R. F., Alvarez, Y., Candore, G., Durand, J., Slattery, J., Hasford, J., Rottenkolber, M., Schmiedl, S., de Abajo Iglesias, F., Gil, M., Gonzalez, R., ... On behalf of the members of work-package 2 of PROTECT (2016). Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project. Pharmacoepidemiology and Drug Safety, 25(supplement S1), 156-165. [DOI] [Repository]
De Groot, M. C. H., Candore, G., Uddin, J., Souverein, P., Ali, M. S., Belitser, S., Huerta, C., Groenwold, R. H. H., Alvarez, Y., Slattery, J., Korevaar, J., Hoes, A. W., Roes, K. C. B., de Boer, A., Douglas, I. J., Schlienger, R. G., Reynolds, R., Klungel, O. H., & Gardarsdottir, H. (2016). Case-only designs for studying the association of antidepressants and hip or femur fracture. Pharmacoepidemiology and Drug Safety, 25(Supplement S1), 103-113. [DOI] [Repository]
Maciel Afonso, A., Schmiedl, S., Becker, C., Tcherny-Lessenot, S., Primatesta, P., Plana, E., Souverein, P., Wang, Y., Korevaar, J. C., Hasford, J., Reynolds, R., de Groot, M. C. H., Schlienger, R., Klungel, O., & Rottenkolber, M. (2016). A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction. European Journal of Clinical Pharmacology, 72(9), 1105–1116. [DOI] [Repository]
Ahmadizar, F., Souverein, P. C., Arets, H. G. M., de Boer, A., & Maitland-van der Zee, A. H. (2016). Asthma related medication use and exacerbations in children and adolescents with type 1 diabetes. Pediatric Pulmonology, 51(11), 1113-1121. [DOI] [Repository]
Ali, M. S., Groenwold, R. H. H., Belitser, S., Souverein, P. C., Martín, E., Gatto, N. M., Huerta, C., Gardarsdottir, H., Roes, K. C. B., Hoes, A. W., de Boer, A., & Klungel, O. H. (2016). Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture. Pharmacoepidemiology and Drug Safety, 25(Suppl 1), 114-121. [DOI] [Repository]
Souverein, P. C., Abbing-Karahagopian, V., Martin, E., Huerta, C., de Abajo, F., Leufkens, H. G. M., Candore, G., Alvarez, Y., Slattery, J., Miret, M., Requena, G., Gil, M. J., Groenwold, R. H. H., Reynolds, R., Schlienger, R. G., Logie, J. W., de Groot, M. C. H., Klungel, O. H., van Staa, T. P., ... Gardarsdottir, H. (2016). Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures. Pharmacoepidemiology and Drug Safety, 25 (Suppl 1), 88-102. [DOI] [Repository]
Verhaegh, B. P. M., de Vries, F., Masclee, A. A. M., Keshavarzian, A., de Boer, A., Souverein, P. C., Pierik, M. J., & Jonkers, D. M. A. E. (2016). High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 43(9), 1004-1013. [DOI] [Repository]
Ahmadizar, F., Fazeli Farsani, S., Souverein, P. C., van der Vorst, M. M., de Boer, A., & Maitland-van der Zee, A. H. (2016). Cardiovascular medication use and cardiovascular disease in children and adolescents with type 1 diabetes: a population-based cohort study. Pediatric Diabetes, 17(6), 433–440. [DOI] [Repository]
Boef, A. G. C., Souverein, P. C., Vandenbroucke, J. P., van Hylckama Vlieg, A., de Boer, A., le Cessie, S., & Dekkers, O. M. (2016). Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives. Pharmacoepidemiology and Drug Safety, 25(3), 317-324. [DOI] [Repository]
Groenwold, R. H. H., de Groot, M. C. H., Ramamoorthy, D., Souverein, P. C., & Klungel, O. H. (2016). Unmeasured confounding in pharmacoepidemiology. Annals of Epidemiology, 26(1), 85-86. [DOI] [Repository]
Requena, G., Huerta, C., Gardarsdottir, H., Logie, J., González-González, R., Abbing-Karahagopian, V., Miret, M., Schneider, C., Souverein, P. C., Webb, D., Afonso, A., Boudiaf, N., Martin, E., Oliva, B., Alvarez, A., De Groot, M. C. H., Bate, A., Johansson, S., Schlienger, R., ... de Abajo, F. J. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiology and Drug Safety, 25(Suppl. S1), 66–78. [DOI] [Repository]
Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P. C., De Bruin, M. L., Slattery, J., De Groot, M. C. H., Hesse, U., Rottenkolber, M., Schmiedl, S., Montero, D., Bate, A., Ruigomez, A., ... de Abajo, F. J. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiology and Drug Safety, 25(S1), 56–65. [DOI] [Repository]
Brauer, R., Ruigómez, A., Downey, G., Bate, A., Garcia Rodriguez, L. A., Huerta, C., Gil, M., de Abajo, F., Requena, G., Alvarez, Y., Slattery, J., de Groot, M., Souverein, P., Hesse, U., Rottenkolber, M., Schmiedl, S., de Vries, F., Tepie, M. F., Schlienger, R., ... Klungel, O. (2016). Prevalence of antibiotic use: a comparison across various European health care data sources. Pharmacoepidemiology and Drug Safety, 25(Suppl. S1), 11-20. [DOI] [Repository]
Fazeli Farsani, S., Souverein, P. C., van der Vorst, M. M. J., Knibbe, C. A. J., Herings, R. M. C., de Boer, A., & Mantel-Teeuwisse, A. K. (2016). Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the Netherlands. Pediatric Diabetes, 17(1), 44–52. [DOI] [Repository]
Other output
Blom, M. T., Eke, E., van Hoeijen, D. A., Souverein, P. C., De Boer, A., & Tan, H. L. (2016). Sudden cardiac arrest risk of non-cardiac depolarization-blocking drugs. Circulation, 134(Suppl 1), Article A19626.
Fazeli Farsani, S., Abdullah-Koolmees, H., Souverein, P. C., De Boer, A., & Mantel-Teeuwisse, A. K. (2016). Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study. Pharmacoepidemiology and Drug Safety, 25(S3), 175-176. [DOI]
Mahmoud Pour, S. H., Baranova, E. V., Souverein, P. C., Asselbergs, F. W., De Boer, A., & Maitland-Van Der Zee, A. (2016). Associations of comorbidities and co-medications with angioedema during the use of angiotensin converting enzyme-inhibitors within the United Kingdom clinical practice research Datalink. Value in Health, 19(3), A39. [DOI]
Noorsyahdy, A., De Boer, A., Deneer, V. H. M., Ten Berg, J. M., Souverein, P. C., & Klungel, O. H. (2016). Population-based effectiveness and safety of different antiplatelet regimens as secondary prevention for ischemic stroke/Transient ischemic attack. Pharmacoepidemiology and Drug Safety, 25(S3), 570. [DOI]
2015
Scholarly publications
Tran-Duy, A., Vanmolkot, F. H., Souverein, P. C., Hoes, A. W., de Boer, A., Stehower, C. D., de Wit, N. J., Joore, M. A., & de Vries, F. (2015). Co-Administration of Proton Pump Inhibitors in Chronic Aspirin Users and the Risk of Adverse Cardiovascular Events: a Population-Based Cohort Study. Value in Health, 18(7), A378-A378.
Abbing-Karahagopian, V., Souverein, P. C., Korevaar, J. C., Leufkens, H. G. M., Egberts, T. C. G., Gardarsdottir, H., & De Bruin, M. L. (2015). Concomitant medication use and its implications on the hazard pattern in pharmacoepidemiological studies: Example of antidepressants, benzodiazepines and fracture risk. Epidemiology Biostatistics and Public Health, 12(3), Article e11273. [DOI] [Repository]
Van Keulen, K., Van Der Linden, P. D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Knol, W. (2015). Risk of Hospitalization for Hypoglycemia in Older Patients with Diabetes Using Antipsychotic Drugs. American Journal of Geriatric Psychiatry, 23(11), 1144-1153. [DOI] [Repository]
Uddin, J., Groenwold, R. H. H., Ali, M. S., Candore, G., De Groot, M. C. H., Souverein, P. C., Alvarez, Y., Belitser, S., Hoes, A. W., De Boer, A., Roes, K. C. B., Klungel, O. H., & Gardarsdottir, H. (2015). Application of the self-controlled case series design in pharmacoepidemiological studies: A cautionary note. European Journal of Epidemiology, 30(8), 903. [DOI] [Repository]
Mahmoud Pour, S. H., Asselbergs, F. W., Souverein, P. C., De Boer, A., & Maitland - van der Zee, A.-H. (2015). Patterns of angiotensin converting enzyme inhibitor prescriptions for different indications: A population-based study. Pharmacoepidemiology and Drug Safety, 24, 202-203. [DOI] [Repository]
Alharbi, F. F., Souverein, P. C., Blom, M. T., Tan, H. L., De Boer, A., & Klungel, O. H. (2015). Use of antihypertensive agents and the risk of out-of-hospital cardiac arrest: A case control study. Pharmacoepidemiology and Drug Safety, 24, 200. [DOI] [Repository]
Yasmina, A., De Boer, A., Klungel, O. H., & Souverein, P. C. (2015). Patterns of antiplatelet use in patients with myocardial infarction and subsequent acute coronary syndrome events. Pharmacoepidemiology and Drug Safety, 24, 119. [DOI] [Repository]
Alharbi, F. F., Souverein, P. C., De Groot, M. C. H., Der Zee, A. H. M.-V., De Boer, A., & Klungel, O. H. (2015). The risk of acute myocardial infarction after discontinuation of antihypertensive agents. Pharmacoepidemiology and Drug Safety, 24, 199-200. [DOI] [Repository]
Uddin, M. J., Groenwold, R. H. H., Ali, M. S., Candore, G., De Groot, M. C. H., Souverein, P. C., Alvarez, Y., Belitser, S., Hoes, A. W., De Boer, A., Roes, K. C. B., Klungel, O., & Gardarsdottir, H. (2015). Impact of violations of the assumptions of the self-controlled case series design in pharmacoepidemiological studies: An example of antidepressants use and the risk of hip fracture. Pharmacoepidemiology and Drug Safety, 24, 2-3. [DOI] [Repository]
Kroger, E., Van Marum, R., Souverein, P., Carmichael, P. H., & Egberts, T. (2015). Treatment with rivastigmine or galantamine and risk of urinary incontinence: Results from a Dutch database study. Pharmacoepidemiology and Drug Safety, 24(3), 276-285. [DOI] [Repository]
Ahmadizar, F., Maitland-Van Der Zee, A.-H., De Boer, A., Souverein, P., & Arets, H. (2015). Asthma medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study. Pharmacoepidemiology and Drug Safety, 24(S1), 275. [DOI] [Repository]
Kröger, E., Mouls, M., Wilchesky, M., Berkers, M., Carmichael, P.-H., van Marum, R., Souverein, P., Egberts, T., & Laroche, M.-L. (2015). Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase. Annals of Pharmacotherapy, 49(11), 1197-1206. [DOI] [Repository]
Van Hoeijen, D. A., Blom, M. T., Bardai, A., Souverein, P. C., De Boer, A., & Tan, H. L. (2015). Reduced pre-hospital and in-hospital survival rates after out-of-hospital cardiac arrest of patients with type-2 diabetes mellitus: An observational prospective community-based study. Europace, 17(5), 753-760. [DOI] [Repository]
Fazeli Farsani, S., Souverein, P. C., Overbeek, J. A., van der Vorst, M. M. J., Knibbe, C. A. J., Herings, R. M. C., de Boer, A., & Mantel-Teeuwisse, A. K. (2015). Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands. British Journal of Clinical Pharmacology, 80(2), 294-303. [DOI] [Repository]
Fazelifarsani, S., Souverein, P. C., van der Vorst, M. M. J., Knibbe, C. A. J., de Boer, A., & Mantel-Teeuwisse, A. K. (2015). Chronic comorbidities in children with type 1 diabetes: a population-based cohort study. Archives of Disease in Childhood, 100(8), 763-8. [DOI] [Repository]
Warnier, M. J., Rutten, F. H., Souverein, P. C., de Boer, A., Hoes, A. W., & De Bruin, M. L. (2015). Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiology and Drug Safety, 24(7), 701-8. [DOI] [Repository]
Mahmoud Pour, S. H., Asselbergs, F. W., Souverein, P., de Boer, A., & Maitland - van der Zee, A.-H. (2015). Angiotensin converting enzyme inhibitors prescribing pattern for different indications: A population based study. Value in Health, 18(7), 1-1. Article PA402. [DOI] [Repository]
Mahmoud Pour, S. H., Asselbergs, F. W., Terreehorst, I., Souverein, P. C., De Boer, A., & Maitland-Van Der Zee, A. H. (2015). Continuation of angiotensin converting enzyme inhibitor therapy, in spite of occurrence of angioedema. International Journal of Cardiology, 201, 644-645. [DOI] [Repository]
Van Keulen, K., Van Der Linden, P. D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Knol, W. (2015). Associatie tussen antipsychoticagebruik en hypoglykemie bij oudere patiënten met diabetes mellitus. Pharmaceutisch Weekblad, 150(16), 88-92. [Repository]
van den Ban, E. F., Souverein, P. C., van Engeland, H., Swaab, H., Egberts, T. C. G., & Heerdink, E. R. (2015). Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands. Social Psychiatry and Psychiatric Epidemiology, 50(7), 1153-1162. [DOI] [Repository]
Been, J. V., Szatkowski, L., van Staa, T.-P., Leufkens, H. G., van Schayck, O. C., Sheikh, A., de Vries, F., & Souverein, P. (2015). Smoke-free legislation and the incidence of paediatric respiratory infections and wheezing/asthma: interrupted time series analyses in the four UK nations. Scientific Reports, 5, 15246. [DOI] [Repository]
Van Den Bogert, C. A., Souverein, P. C., Brekelmans, C. T. M., Janssen, S. W. J., Van Hunnik, M., Koëter, G. H., Leufkens, H. G. M., & Bouter, L. M. (2015). Occurrence and determinants of selective reporting of clinical drug trials: Design of an inception cohort study. BMJ Open, 5(7), Article e007827. [DOI] [Repository]
Mahmoud Pour, S. H., Asselbergs, F. W., de Keyser, C. E., Souverein, P. C., Hofman, A., Stricker, B. H. C., de Boer, A., & van der Zee, A. H. (2015). Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors. International Journal of Clinical Pharmacy, 37, 1095–1103. [DOI] [Repository]
Veldhuis-Vlug, A. G., Oei, L., Souverein, P. C., Tanck, M. W. T., Rivadeneira, F., Zillikens, M. C., Kamphuisen, P. W., Maitland-van der Zee, A. H., de Groot, M. C. H., Hofman, A., Uitterlinden, A. G., Fliers, E., de Boer, A., & Bisschop, P. H. (2015). Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density. Osteoporosis International, 26(7), 2019-2027. [DOI] [Repository]
Other output
Verhaegh, B. P. M., De Vries, F., Masclee, A. A., Keshavarzian, A., De Boer, A., Souverein, P., Jonkers, D. M., & Pierik, M. J. (2015). Medication-induced microscopic colitis: Do recency and duration of use matter? Journal of Crohn's and Colitis, 9, 6-7. Article OP010. [DOI]
Tran-Duy, A., Vanmolkot, F. H., Souverein, P. C., Hoes, A. W., de Boer, A., Stehower, C. D., de Wit, N. J., Joore, M. A., & de Vries, F. (2015). Co-Administration of Proton Pump Inhibitors in Chronic Aspirin Users and the Risk of Adverse Cardiovascular Events: a Population-Based Cohort Study. Value in Health, 18(7), 378. Article PCV28. [DOI]
2014
Scholarly publications
Klop, C., Welsing, P. M. J., Elders, P. J. M., Overbeek, J. A., Souverein, P., Leufkens, H. G. M., Bijlsma, J. W. J., & De Vries, F. (2014). Persistence to osteoporosis drugs following an incident osteoporotic fracture: The prefrac study. Osteoporosis International, 25(6), 662. [DOI]
Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., De Abajo, F., Leufkens, H. G. M., Slattery, J., Alvarez, Y., Miret, M., Gil, M., Oliva, B., Hesse, U., Requena, G., De Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlienger, R. G., De Groot, M. C. H., Klungel, O. H., ... De Bruin, M. L. (2014). Antidepressant prescribing in five European countries: Application of common definitions to assess the prevalence, clinical observations, and methodological implications. European Journal of Clinical Pharmacology, 70(7), 849-857. [DOI]
Ali, MS., De Groot, M., Candore, G., Groenwold, R. H. H., Souverein, P. C., Alvarez, Y., Uddin, M. J., Hoes, A. W., De Boer, A., Klungel, O. H., & Gardarsdottir, H. (2014). Antidepressantuse and the risk of hip fracture: A self-controlled case series approach in two primary care databases. Pharmacoepidemiology and Drug Safety, 23, 385. [DOI]
van den Ban, E., Souverein, P., Meijer, W., van Engeland, H., Swaab, H., Egberts, T., & Heerdink, R. (2014). Association between ADHD drug use and injuries among children and adolescents. European child & adolescent psychiatry, 23(2), 95-102. [DOI]
Requena, G., Abbing-Karahagopian, V., Huerta, C., De Bruin, M. L., Alvarez, Y., Miret, M., Hesse, U., Gardarsdottir, H., Souverein, P. C., Slattery, J., Schneider, C., Rottenkolber, M., Schmiedl, S., Gil, M., De Groot, M. C. H., Bate, A., Ruigómez, A., García Rodríguez, L. A., Johansson, S., ... De Abajo, F. J. (2014). Incidence rates and trends of hip/femur fractures in five European countries: Comparison using e-healthcare records databases. Calcified Tissue International, 94(6), 580-589. [DOI]
de Groot, M. C. H., Schuerch, M., de Vries, F., Hesse, U., Oliva, B., Gil, M., Huerta, C., Requena, G., de Abajo, F., Afonso, A. S., Souverein, P. C., Alvarez, Y., Slattery, J., Rottenkolber, M., Schmiedl, S., Van Dijk, L., Schlienger, R. G., Reynolds, R., & Klungel, O. H. (2014). Antiepileptic drug use in seven electronic health record databases in Europe: a methodologic comparison. Epilepsia, 55(5), 666-673. [DOI]
Van Hoeijen, D. A., Blom, M. T., Bardai, A., Souverein, P. C., De Boer, A., & Tan, H. L. (2014). Reduced prehospital survival rate after out-of-hospital cardiac arrest in patients with diabetes mellitus type 2: A prospective community-based study. Circulation, 130.
Fazelifarsani, S., Souverein, P. C., van der Vorst, M. M. J., Mantel-Teeuwisse, A. K., Knibbe, C. A. J., & de Boer, A. (2014). Disease history and medication use as risk factors for the clinical manifestation of type 1 diabetes in children and young adults: an explorative case control study. PLoS One, 9(2), e87408. [DOI] [Repository]
Wouters, H., Van Dijk, L., Van Geffen, E. C. G., Geers, H. C. J., Souverein, P. C., Bouvy, M. L., & Stiggelbout, A. M. (2014). Do the benefits of statins outweigh their drawbacks? Assessing patients' trade-off preferences with conjoint analysis. International Journal of Cardiology, 176(3), 1220-1222. [DOI]
Fazeli Farsani, S., Souverein, P. C., van der Vorst, M. M. J., Knibbe, C. A. J., de Boer, A., & Mantel - Teeuwisse, A. (2014). Population-based cohort study of anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents. Antimicrobial Agents and Chemotherapy, 58(8), 4666-4674. [DOI] [Repository]
Blom, M. T., van Hoeijen, D. A., Bardai, A., Berdowski, J., Souverein, P. C., De Bruin, M. L., Koster, R. W., de Boer, A., & Tan, H. L. (2014). Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry. Open Heart, 1(1), Article e000112. [DOI] [Repository]
Vervloet, M., van Dijk, L., de Bakker, D. H., Souverein, P. C., Santen-Reestman, J., van Vlijmen, B., van Aarle, M. C. W., van der Hoek, L. S., & Bouvy, M. L. (2014). Short- and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with Type 2 diabetes: evidence from a randomized controlled trial. Diabetic Medicine, 31(7), 821–828. [DOI]
van den Bogert, C. A., Souverein, P. C., Putzeist, M., Leufkens, H. G. M., Janssen, S. W. J., & Koëter, G. H. (2014). Regulatory watch: Outcomes of EMA marketing authorization applications: does partnering have an influence? Nature Reviews. Drug Discovery, 13(12), 878. [DOI]
Duijnhoven, R. G., Straus, S. M. J. M., Souverein, P. C., de Boer, A., Bosch, J. L. H. R., Hoes, A. W., & De Bruin, M. L. (2014). Long-term Use of 5α-Reductase Inhibitors and the Risk of Male Breast Cancer. Cancer Causes & Control, 25(11), 1577-1582. [DOI]
van Steenis, M. N. A., Driesenaar, J. A., Van Hulten, R. P., Souverein, P. C., van Dijk, C. E. M. J., de Smet, P. G. A. M., & van Dulmen, A. M. (2014). Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids. Patient Preference and Adherence, 8, 83-91.
Other output
Ali, M. S., De Groot, M., Candore, G., Groenwold, R. H. H., Souverein, P. C., Alvarez, Y., Uddin, M. J., Hoes, A. W., de Boer, A., Klungel, O. H., & Gardarsdottir, H. (2014). Antidepressant Use and the Risk of Hip Fracture: A Self-Controlled Case Series Approach in Two Primary Care Databases. Pharmacoepidemiology and Drug Safety, 23, 385-385.
Requena, G., Huerta, C., Gardarsdottir, H., Miret, M., Martin, E., Souverein, P. C., Schneider, C., Gonzalez-Gonzalez, R., Bate, A., Alvarez, Y., Montero, D., Garcia-Rodriguez, L. A., Reynolds, R., Schlienger, R. G., de Groot, M. C. H., Klungel, O. H., & de Abajo, F. J. (2014). Risk of Hip Fractures Associated with Benzodiazepines: Common Methodology But Different Results in a Multi-Site Cohort Study. The PROTECT Project. Pharmacoepidemiology and Drug Safety, 23(S1), 383-384. Article 715. [Repository]
Abbing-Karahagopian, V., Souverein, P., Martin, E., Huerta, C., de Abajo, F., Leufkens, H., Candore, G., Alvarez, Y., Slattery, J., Miret, M., Requena, G., Gil, M., Groenwold, R., Reynolds, R., Schlienger, R., de Groot, M., Klungel, O. H., van Staa, T., Egberts, T., ... Gardarsdottir, H. (2014). Understanding Inconsistent Results from Observational Pharmacoepidemiological Studies: the Case of Antidepressant Use and Risk of Hip Fracture. Pharmacoepidemiology and Drug Safety, 23, 36-36.
Souverein, P. C., & Gardarsdottir, H. (2014). (Non)availability of Dosage Instructions in Electronic Health Care Databases and Exposure (mis)classification: the Example of Antidepressants. Pharmacoepidemiology and Drug Safety, 23, 36-37.
De Groot, M. C. H., Belitser, S. V., Souverein, P. C., Groenwold, R. H. H., Candore, G., Alvarez, Y., Schlienger, R. G., Reynolds, R., Klungel, O. H., & Gardarsdottir, H. (2014). Impact of varying control moment selection in a case-crossover (CCO) study on antidepressant drug (AD) use and hip/femur fracture (HFF) in protect. Pharmacoepidemiology and Drug Safety, 23(S1), 407-408. Article 758. [DOI] [Repository]
Souverein, P. C., De Groot, M. C. H., Martin, E., Huerta, C., Candore, G., Alvarez, Y., Slattery, J., Schlienger, R. G., Reynolds, R., Klungel, O. H., & Gardarsdottir, H. (2014). No impact of adjusting for lifestyle factors or general practice on risk estimates for the association between antidepressants and hip/femur fracture. Pharmacoepidemiology and Drug Safety, 23(S1), 384-385. Article 716. [DOI] [Repository]
Requena, G., Logie, J., González-González, R., Gardarsdottir, H., Afonso, A., Souverein, P. C., Merino, E. M., Boudiaf, N., Huerta, C., Bate, A., Alvarez, Y., García-Rodríguez, L. A., Reynolds, R., Schlienger, R. G., De Groot, M. C. H., Klungel, O. H., & De Abajo, F. J. (2014). Risk of hip fractures associated with benzodiazepines: Applying common protocol to a multi-database nested case-control study. The protect project. Pharmacoepidemiology and Drug Safety, 23, 44. Article 80. [DOI] [Repository]
Warnier, M., Rutten, F., Souverein, P., Hoes, A., De Boer, A., & De Bruin, M. (2014). Are ECG monitoring recommendations before prescription of QT prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiology and Drug Safety, 23(S1), 228-229. Article 434. [DOI]
Ali, M. S., Groenwold, R. H. H., Belitser, S. V., Souverein, P. C., Gardarsdottir, H., Hoes, A. W., De Boer, A., & Klungel, O. H. (2014). Antidepressant use and risk of hip fracture: A comparison of marginal structural models, conventional regression and propensity score methods. Pharmacoepidemiology and Drug Safety, 23(S1), 199. Article 377. [DOI] [Repository]
Fazelifarsani, S., Souverein, P. C., Van Der Vorst, M. M. J., Knibbe, C. A. J., De Boer, A., & Mantel-Teeuwisse, A. K. (2014). Chronic comorbidities in children and adolescents with type 1 diabetes. Pharmacoepidemiology and Drug Safety, 23(S1), 185. Article 351. [DOI] [Repository]
Pour, S. H. M., De Keyser, C. E., Souverein, P. C., Asselbergs, F. W., Hofman, A., Stricker, B. H., De Boer, A., & Maitland-Van Der Zee, A.-H. (2014). Discontinuation of angiotensin converting enzyme inhibitors (ACEIs) as a potential marker for adverse drug reactions (ADRs). Pharmacoepidemiology and Drug Safety, 23(S1), 379. [DOI]
Fazelifarsani, S., Souverein, P. C., Van Der Vorst, M. M. J., Knibbe, C. A. J., Herings, R. M. C., De Boer, A., & Mantel-Teeuwisse, A. K. (2014). Increasing trend of type 1 diabetes in Dutch children and adolescents (1998-2010). Pharmacoepidemiology and Drug Safety, 23(S1), 184. Article 349. [DOI] [Repository]
2013
Scholarly publications
De Groot, M. C. H., Schuerch, M., De Vries, F., Hesse, U., Oliva, B., Huerta Alvarez, C., Gil, M., Requena, G., Abajo, F., Afonso, A., Souverein, P. C., Alvarez, Y., Slattery, J., Rottenkolber, M., Schmiedl, S., Van Dijk, L., Schlienger, R. G., Reynolds, R., & Klungel, O. (2013). Antiepileptic Drug Use in Seven Electronic Health Record Databases in Europe: A Methodological Comparison. Pharmacoepidemiology and Drug Safety, 22, 289-290.
Requena, G., Abbing-Karahagopian, V., Huerta, C., De Bruin, M. L., Alvarez, Y., Miret, M., Hesse, U., Gardarsdottir, H., Souverein, P., Slattery, J., Schneider, C., Rottenkolber, M., Schmiedl, S., Gil, M., De Groot, M. C. H., Bate, A., Ruigomez, A., Garcia, L. A., Johanson, S., ... De Abajo, F. J. (2013). Trends in Incidence Rates (IR) of Hip/Femur Fractures in Five European Countries: A Comparison Using Electronic Health Care Records (e-HCR). Pharmacoepidemiology and Drug Safety, 22, 408-409.
Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P., Slattery, J., De Groot, M. C. H., Hesse, U., Rottenkolber, M., Schmiedl, S., Montero, D., Bate, A., Ruigomez, A., Garcia, L. A., ... De Abajo, F. J. (2013). Prevalence of Use of Benzodiazepines and Related Drugs in Seven European Databases: A Cross-National Descriptive Study from the PROTECT-EU Project. Pharmacoepidemiology and Drug Safety, 22, 472-472.
Van Melick, E. J. M., Souverein, P. C., Den Breeijen, J. H., Tusveld, C. E., Egberts, T. C. G., & Wilting, I. (2013). Age as a determinant of instability of serum lithium concentrations. Therapeutic Drug Monitoring, 35(5), 643-648. [DOI]
Duijnhoven, R. G., Straus, S. M. J. M., Souverein, P. C., De Boer, A., Hoes, A. W., & De Bruin, M. L. (2013). Male breast cancer in users of finasteride and dutasteride: A case-control study. Pharmacoepidemiology and Drug Safety, 22, 355. [DOI]
Fazeli Farsani, S., Souverein, P. C., Van Der Vorst, M. M. J., Knibbe, C. A. J., & De Boer, A. (2013). Medication use and disease history as risk factors for the clinical manifestation of type 1 diabetes mellitus. Pharmacoepidemiology and Drug Safety, 22, 336-337. [DOI]
Fazeli Farsani, S., Souverein, P. C., Van Der Vorst, M. M. J., Knibbe, C. A. J., & De Boer, A. (2013). Prevalence and patterns of anti-infective medication use in children with type 1 diabetes mellitus. Pharmacoepidemiology and Drug Safety, 22, 336. [DOI]
Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P., Slattery, J., De Groot, M. C. H., Hesse, U., Rottenkolber, M., Schmiedl, S., Montero, D., Bate, A., Ruigomez, A., García, L. A., ... De Abajo, F. J. (2013). Prevalence of use of benzodiazepines and related drugs in seven european databases: A cross-national descriptive study from the protect-eu project. Pharmacoepidemiology and Drug Safety, 22, 472. [DOI]
Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G. M., Slattery, J., Alvarez, Y., Montserrat, M., Gil, M., Hesse, U., Requena, G., de Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlinger, R., de Groot, M., Klungel, O. H., van Staa, T. P., ... De Bruin, M. L. (2013). Antidepressant Prescribing in Five European Countries: Application of Common Methods to Assess the Variation in Prevalence. Pharmacoepidemiology and Drug Safety, 22(S1), 279-280. [DOI]
Stuijver, D. J. F., Majoor, C. J., van Zaane, B., Souverein, P. C., de Boer, A., Dekkers, O. M., Büller, H. R., & Gerdes, V. E. A. (2013). Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest, 143(5), 1337-1342. [DOI]
Sino, C. G. M., Stuffken, R., Heerdink, E. R., Schuurmans, M. J., Souverein, P. C., & Egberts, A. C. G. (2013). The association between prescription change frequency, chronic disease score and hospital admissions: a case control study. BMC pharmacology & toxicology, 14, 39.
Warnier, M. J., Blom, M. T., Bardai, A., Berdowksi, J., Souverein, P. C., Hoes, A. W., Rutten, F. H., de Boer, A., Koster, R. W., De Bruin, M. L., & Tan, H. L. (2013). Increased risk of sudden cardiac arrest in obstructive pulmonary disease: a case-control study. PLoS One, 8(6), 1-8. Article e65638. [DOI]
van Melick, E. J. M., Souverein, P. C., den Breeijen, J. H., Tusveld, C. E., Egberts, A. C. G., & Wilting, I. (2013). Age as a Derminant of Instability of Serum Lithium Concentrations. Therapeutic Drug Monitoring, 35(5), 643-648.
Blom, M. T., Warnier, M. J., Bardai, A., Berdowski, J., Koster, R. W., Souverein, P. C., Hoes, A. W., Rutten, F. H., de Boer, A., De Bruin, M. L., & Tan, H. L. (2013). Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease. Resuscitation, 84(5), 569-74. [DOI]
Bardai, A., Amin, A. S., Blom, M. T., Bezzina, C. R., Berdowski, J., Langendijk, P. N. J., Beekman, L., Klemens, C. A., Souverein, P. C., Koster, R. W., de Boer, A., & Tan, H. L. (2013). Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community. European Heart Journal, 34(20), 1506-16. [DOI]
Smans, L. C. C. J., Souverein, P. C., Leufkens, H. G. M., Hoepelman, A. I. M., & Zelissen, P. M. J. (2013). Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study. European Journal of Endocrinology, 168(4), 609-614.
de Jong, H. J. I., Damoiseaux, J. G., Vandebriel, R. J., Souverein, P. C., Gremmer, E. R., Wolfs, M., Klungel, O. H., van Loveren, H., Cohen Tervaert, J. W., & Verschuren, W. M. (2013). Statin use and markers of immunity in the doetinchem cohort study. PLoS One, 8(10).
Biere-Rafi, S., Hutten, B. A., Squizzato, A., Ageno, W., Souverein, P. C., de Boer, A., Gerdes, V. E. A., Büller, H. R., Kamphuisen, P. W., & de Boer, A. (2013). Statin treatment and the risk of recurrent pulmonary embolism. European Heart Journal, 34(24), 1800-6. [DOI]
Professional publications
Stuffken, R., Souverein, P. C., Egberts, A. C. G., & Heerdink, E. R. (2013). Discontinuïteit in gebruik van psychofarmaca bij ziekenhuisopname. PW Wetenschappelijk Platform, 7(7), a1322.
Other output
De Groot, M. C. H., Schuerch, M., De Vries, F., Hesse, U., Oliva, B., Alvarez, C. H., Gil, M., Requena, G., Abajo, F., Afonso, A., Souverein, P. C., Alvarez, Y., Slattery, J., Rottenkolber, M., Schmiedl, S., Van Dijk, L., Schlienger, R. G., Reynolds, R., & Klungel, O. (2013). Antiepileptic drug use in seven electronic health record databases in europe: A methodological comparison. Pharmacoepidemiology and Drug Safety, 22(s1), 289-290. Article 585. [DOI]
Brauer, R., Ruigómez, A., Downey, G., Bate, A., Rodriguez, L. A. G., Huerta, C., Oliva, B., Gil, M., Abajo, F., Requena, G., Alvarez, Y., Slattery, J., de Groot, M., Souverein, P., Hesse, U., Rottenkolber, M., Schmiedl, S., de Vries, F., Tepie, M. F., ... Klungel, O. (2013). Prevalence of antibiotic use: A methodological comparison across various European health care data sources. Pharmacoepidemiology and Drug Safety, 22(s1), 457. Article 912. [DOI]
De Groot, M. C. H., Van Den Ham, R., De Bruin, M., Alvarez, C. H., Gill, M., Afonso, A., Requena, G., Hesse, U., Rønn, P. F., Souverein, P. C., Alvarez, Y., Slattery, J., Rottenkolber, M., Schmiedl, S., Van Dijk, L., Schlienger, R. G., Reynolds, R., Klungel, O. H., & Grimaldi-Bensouda, L. (2013). Comparison of seven electronic healthcare databases in eu countries using a standardized methodology; a descriptive study on the exposure to calcium-channel blockers (CCBS). Pharmacoepidemiology and Drug Safety, 22(s1), 290-291. Article 586. [DOI]
Afonso, A. S., De Groot, M. C. H., Van Den Ham, R., Bruin, M. L., Alvarez, C. H., Gil, M., Hesse, U., Rønn, P. F., Souverein, P. C., Alvarez, Y., Slattery, J., Rottenkolber, M., Van Dijk, L., Schlienger, R. G., Reynolds, R., Klungel, O. H., & Grimaldi-Bensouda, L. (2013). Comparison of six electronic healthcare databases in Europe using standardized protocols: A descriptive study on the incidence of cancer. Pharmacoepidemiology and Drug Safety, 22(s1), 285. Article 576. [DOI]
Requena, G., Abbing-Karahagopian, V., Huerta, C., De Bruin, M. L., Alvarez, Y., Miret, M., Hesse, U., Gardarsdottir, H., Souverein, P., Slattery, J., Schneider, C., Rottenkolber, M., Schmiedl, S., Gil, M., De Groot, M. C. H., Bate, A., Ruigómez, A., García, L. A., Johanson, S., ... De Abajo, F. J. (2013). Trends in incidence rates (IR) of hip/femur fractures in five european countries: A comparison using electronic health care records (E-HCR). Pharmacoepidemiology and Drug Safety, 22(s1), 408-409. Article 811. [DOI]
Lamberts, E. J. F., Souverein, P. C., Hugtenburg, J. G., Nijpels, G., & Bouvy, M. L. (2013). Achieving glycemic control differs between patients with type 2 diabetes mellitus starting on metformin and sulfonylureas. Pharmacoepidemiology and Drug Safety, 22(s1), 184. Article 378. [DOI]
Lamberts, E. J. F., Hugtenburg, J. G., Nijpels, G., Bouvy, M. L., & Souverein, P. C. (2013). Long-term follow up of concomitant medication use in type 2 diabetes patients: A cohort study. Pharmacoepidemiology and Drug Safety, 22(S1), 404. Article 803. [DOI]
2012
Scholarly publications
Warnier, M. J., Blom, M., Bardai, A., Souverein, P. C., Hoes, A. W., Rutten, F., De Boer, A., De Bruin, M. L., & Tan, H. L. (2012). Patients with obstructive pulmonary disease have an increased risk of ecg documented out-of-hospital cardiac arrest. Pharmacoepidemiology and Drug Safety, 21, 265. [DOI]
Lamberts, E. J. F., Nijpels, G., Welschen, L. M. C., Hugtenburg, J. G., Dekker, J. M., Souverein, P. C., & Bouvy, M. L. (2012). Discontinuation of statins among patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews, 28, 241-245.
de Jong, H. J. I., Saldi, S. R. F., Klungel, O. H., Vandebriel, R. J., Souverein, P. C., Meyboom, R. H. B., Passier, J. L. M., van Loveren, H., & Tervaert, J. W. C. (2012). Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: A case/non-case approach. PLoS One, 7(7), e41289. Article e41289. [DOI]
van Melick, E. J., Wilting, I., Souverein, P. C., & Egberts, A. C. G. (2012). Differences in lithium use patterns in the Netherlands: comparing middle-aged and older patients in a database study. American Journal of Geriatric Pharmacotherapy, 10(3), 193-200. http://www.ncbi.nlm.nih.gov/pubmed/22417731
Kroger, E., Berkers, M., Carmichael, P. H., Souverein, P. C., van Marum, R. J., & Egberts, A. C. G. (2012). Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands. American Journal of Geriatric Pharmacotherapy, 10(6), 373-380. http://www.ncbi.nlm.nih.gov/pubmed/23217530
Hoebert, J. M., Souverein, P. C., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., & van Dijk, C. E. M. J. (2012). Reimbursement Restriction and Moderate Decrease in Benzodiazepine Use in General Practice. Annals of Family Medicine, 10, 42-49.
de Vries, F., & Souverein, P. (2012). Interpretation of the Association between Beta-Blockers and Hip/Femur Fracture. American Journal of Nephrology, 35(1), 101-102. [DOI]
Professional publications
Hoebert, J., Souverein, P., Mantel-Teeuwisse, A., Leufkens, H., & Van Dijk, L. (2012). Benzodiazepinegebruik daalt als de gebruiker zelf betaalt. Huisarts en Wetenschap, 55(7), 286-288. [DOI]
Other output
Abbing-Karahagopian, V., Gardarsdottir, H., Souverein, P. C., Klungel, O. H., Leufkens, B. G. M., Egberts, T. C. G., & De Bruin, M. L. (2012). Timing of concomitant drug use in pharmacoepidemiological studies. Pharmacoepidemiology and Drug Safety, 21(S3), 423. Article 914. [DOI]
2011
Scholarly publications
Van Zaane, B., Squizzato, A., Biere-Rafi, S., Souverein, P. C., Brandjes, D. P. M., Buller, H. R., Gerdes, V. E. A., & De Boer, A. (2011). Thyroid disease, antithyroid or thyreomimetic agents, and the risk of pulmonary embolism. Journal of Thrombosis and Haemostasis, 9, 413. [DOI]
Biere-Rafi, S., Di Nisio, M., Gerdes, V., Porreca, E., Souverein, P., de Boer, A., Büller, H., & Kamphuisen, P. (2011). Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism. Pharmacoepidemiology and Drug Safety, 20(6), 635-642. [DOI]
Harmsze, A. M., VanWerkum, J. W., Souverein, P. C., Bouman, H. J., Hackeng, C. M., Ruven, H. J. T., Ten Berg, J. M., Klungel, O. H., de Boer, A., & Deneer, V. H. M. (2011). Combined influence of PPIs, CCBs and CYP2C19∗2 on on-treatment platelet reactivitiy and on the occurrence of atherothrombotic events in patients undergoing coronary stent implantation. European Heart Journal, 32, 239-240. [DOI]
de Jong, H. J. I., Cohen Tervaert, J. W., Saldi, S. R. F., Vandebriel, R. J., Souverein, P. C., Meyboom, R. H. B., van Loveren, H., & Klungel, O. H. (2011). Association Between Statin Use and Lupus-Like Syndrome Using Spontaneous Reports. Seminars in Arthritis & Rheumatism, 41(3), 373-381. [DOI]
Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., & de Vries, F. (2011). Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporosis International, 22(7), 2197-204. [DOI]
de Peuter, O. R., Souverein, P. C., Klungel, O. H., Büller, H. R., de Boer, A., & Kamphuisen, P. W. (2011). Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failure. European Journal of Heart Failure, 13(2), 220-6. [DOI]
Meijvis, S. C. A., Cornips, M. C., Voorn, G. P., Souverein, P. C., Endeman, H., Biesma, D. H., Leufkens, H. G. M., & van de Garde, E. M. W. (2011). Microbial evaluation of proton-pump inhibitors and the risk of pneumonia. European Respiratory Journal, 38(5), 1165-1172.
Lamberts, E. J. F., Nijpels, G., Welschen, L. M., Hugtenburg, J. G., Dekker, J. M., Souverein, P. C., & Bouvy, M. L. (2011). Long term patterns of use after initiation of oral antidiabetic drug therapy. Pharmacoepidemiology and Drug Safety, 20(4), 351-8.
Verdel, B. M., Souverein, P. C., Meenks, S. D., Heerdink, E. R., Leufkens, H. G. M., & Egberts, A. C. G. (2011). Use of serotonergic drugs and the risk of bleeding. Clinical Pharmacology and Therapeutics, 89(1), 89-96.
De Peuter, O. R., Lip, G. Y., Souverein, P. C., Klungel, O. H., de Boer, A., Buller, H. R., & Kamphuisen, P. W. (2011). Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study. European Journal of Heart Failure, 13(5), 489-495.
Harmsze, A. M., Van Werkum, J. W., Souverein, P. C., Breet, N. J., Bouman, H. J., Hackeng, C. M., Ruven, H. J. T., Ten Berg, J. M., Klungel, O. H., De Boer, A., & Deneer, V. H. M. (2011). Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention. Journal of Thrombosis and Haemostasis, 9(10), 1892-1901. [DOI]
Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., & de Vries, F. (2011). Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporosis International, 22(7), 2197-204. http://www.ncbi.nlm.nih.gov/pubmed/20967420
Professional publications
Velthove, K. J., Souverein, P. C., Schweizer, R. C., van Solinge, W. W., & Leufkens, H. G. M. (2011). Multidisciplinaire aanpak bij ernstige obstructieve longziekten. Risico op ziekte in kaart met biomarkers. Pharmaceutisch Weekblad, 17, 16-18.
Other output
de Boer, A., Harmsze, A. M., Deneer, V. H. M., Maitland - van der Zee, A.-H., Peters, B. J. M., Souverein, P. C., Van Werkum, J. W., ten Berg, J. M., Tjoeng, M. M., & Klungel, O. (2011). Interactions between CES2, CYP2C9, UGT1A6 and COX1 genetic variants and acetylsalicylic acid modify the risk of myocardial infarction. Basic & Clinical Pharmacology & Toxicology, 109, 102. [DOI]
De Jong, H. J., Saldi, S. R., Klungel, O. H., Vandebriel, R. J., Souverein, P. C., Meyboom, R. H., Passier, A., Van Loveren, H., & Tervaert, J. W. C. (2011). The association between statin use and polymyalgia rheumatica/arteritis temporalis: Demonstrated by spontaneous reports and self-described case-reports. Pharmacoepidemiology and Drug Safety, 20(S1), S67. Article 155. [DOI]
2010
Scholarly publications
van den Ban, E., Souverein, P. C., Swaab, H., van Engeland, H., Egberts, T. C. G., & Heerdink, E. R. (2010). Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the netherlands. ADHD Attention Deficit and Hyperactivity Disorders, 2(4), 213-220. [DOI] [Portal]
Arbouw, M., Lalmohamed, A., Souverein, P., Egberts, A., Bazelier, M., & De Vries, F. (2010). Use of dopaminergic drugs and risk of hip or femur fracture: A population-based case-control study. Bone, 47, 29. [DOI]
Biere-Rafi, S., Gerdes, V., Hutten, B., Squizzato, A., Ageno, W., Souverein, P., De Boer, A., Buller, H. R., & Kamphuisen, P. (2010). Statin treatment reduces the incidence of recurrent pulmonary embolism: A population based case-control study. Blood, 116(21).
Biere-Rafi, S., Gerdes, V. E. A., Hutten, B. A., Squizzato, A., Ageno, W., Souverein, P. C., De Boer, A., Büller, H. R., & Kamphuisen, P. W. (2010). Statin treatment for primary and secondary prevention of pulmonary embolism: A population based case-control study. Pathophysiology of Haemostasis and Thrombosis, 37, 1. [DOI]
Pouwels, S., Lalmohamed, A., van Staa, T., Cooper, C., Souverein, P., Leufkens, H. G., Rejnmark, L., de Boer, A., Vestergaard, P., & de Vries, F. (2010). Use of organic nitrates and the risk of hip fracture: a population-based case-control study. Journal of Clinical Endocrinology and Metabolism, 95(4), 1924-31. [DOI]
Gardarsdottir, H., Souverein, P. C., Egberts, T. C. G., & Heerdink, E. R. (2010). Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. Journal of Clinical Epidemiology, 63(4), 422-7. [DOI]
Verdel, B. M., Souverein, P. C., Egberts, T. C. G., van Staa, T. P., Leufkens, H. G. M., & de Vries, F. (2010). Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures: Focus on the affinity for the serotonin receptor. Bone, 47(3), 604-609. [DOI]
van den Ban, E. F., Souverein, P. C., Swaab, H., van Engeland, H., Egberts, A. C. G., & Heerdink, E. R. (2010). Less discontunuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands. ADHD Attention Deficit and Hyperactivity Disorders, 2, 213-220.
Velthove, K. J., Leufkens, H. G. M., Schweizer, R. C., van Solinge, W. W., & Souverein, P. C. (2010). Medication Changes Prior to Hospitalization for Obstructive Lung Disease: A Case-Crossover Study. Annals of Pharmacotherapy, 44(2), 267-273.
Velthove, K. J., Leufkens, H. G. M., Souverein, P. C., Schweizer, R. C., & van Solinge, W. W. (2010). Testing bias in clinical databases: methodological considerations. Emerging Themes in Epidemiology [E], 7(1), 2. http://www.ncbi.nlm.nih.gov/pubmed/20470397
Mannesse, C. K., van Puijenbroek, E. P., Jansen, P. A. F., van Marum, R. J., Souverein, P. C., & Egberts, A. C. G. (2010). Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase. Drug Safety, 33(7), 569-78. [DOI]
Stolk, P., Souverein, P. C., Wilting, I., Leufkens, H. G. M., Klein, D. F., Rapoport, S. I., & Heerdink, E. R. (2010). Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins, Leukotrienes and Essential Fatty Acids, 82(1), 9-14.
Velthove, K. J., Leufkens, H. G. M., Souverein, P. C., Schweizer, R. C., Bracke, M., & van Solinge, W. W. (2010). Effects of glucocorticoids on the neutrophil count: A cohort study among hospitalized patients. Pulmonary Pharmacology & Therapeutics, 23(2), 129-134.
Velthove, K. J., Souverein, P. C., van Solinge, W. W., Leufkens, H. G. M., & Lammers, J. W. J. (2010). Measuring exacerbations in obstructive lung disease. Pharmacoepidemiology and Drug Safety, 19, 367-374.
Velthove, K. J., Souverein, P. C., van Solinge, W. W., Leufkens, H. G. M., & Lammers, J. W. J. (2010). Effects of corticosteroid use on readmission in obstructive lung disease. Respiratory Medicine, 104(2), 211-218.
Professional publications
Velthove, K. J., Leufkens, H. G. M., Schweizer, R. C., van Solinge, W. W., & Souverein, P. C. (2010). Veranderingen in geneesmiddelengebruik voorafgaand aan ziekenhuisopname wegens obstructieve longziekten. Pharmaceutisch Weekblad, 4(6), 104-108.
Other output
De Peuter, O., Lip, G. Y. H., Souverein, P. C., Klungel, O. H., de Boer, A., Büller, H. R., & Kamphuisen, P. W. (2010). Time-trends in treatment and cardiovascular events in patients with heart failure: A pharmacosurveillance study. 39. [DOI]
De Peuter, O. R., Souverein, P. C., Klungel, O. H., Lip, G. Y., Buller, H. R., De Boer, A., & Kamphuisen, P. W. (2010). Non-selective beta-blockers decrease thrombotic events in patients with heart failure. 268. [DOI]
De Peuter, O. R., Lip, G. Y. H., Souverein, P. C., Klungel, O. H., De Boer, A., Buller, H. R., & Kamphuisen, P. W. (2010). Time-trends in treatment and cardiovascular events in patients with heart failure: A pharmacosurveillance study. 1052-1053. [DOI]
Kröger, E., van Marum, R. J., Souverein, P. C., Carmichael, P. H., & Egberts, A. C. G. (2010). Treatment with Cholinesterase Inhibitors May Increase the Risk of Urinary Incontinence. S131, 305. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Verdel, B. M., Souverein, P. C., Heerdink, E. R., Leufkens, H. G. M., & Egberts, A. C. G. (2010). Use of Serotonergic Drugs and the Risk of Bleeding. S166, 390. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
2009
Scholarly publications
Arbouw, M., Movig, K., van Staa, T., Egberts, T., Souverein, P., & de Vries, F. (2009). Use of Dopaminergic Drugs and Risk of Hip or Femur Fracture: A Population-Based Case-Control Study. Pharmacoepidemiology and Drug Safety, 18, S201-S202.
De Peuter, O. R., Souverein, P. C., Klungel, O. H., De Boer, A., Büller, H. R., & Kamphuisen, P. W. (2009). Non-selective beta-blockers decrease thrombotic events in patients with heart failure. Journal of Thrombosis and Haemostasis, 7(S2), 215. http://hdl.handle.net/11370/9ad01c77-c6e3-4f17-a179-d48877bc82b2
Kars, M., Souverein, P. C., Herings, R. M. C., Romijn, J. A., Vandenbroucke, J. P., de Boer, A., & Dekkers, O. M. (2009). Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism, 94(8), 2729-34. [DOI]
Verdel, B. M., Souverein, P. C., Meyboom, R. H. B., Kardaun, S. H., Leufkens, H. G. M., & Egberts, A. C. G. (2009). Risk of drug-induced photosensitivity: focus on spectroscopic and molecular characteristics. Pharmacoepidemiology and Drug Safety, 18(5), 602-609.
Velthove, K. J., Bracke, M., Souverein, P. C., Schweizer, R. C., ten Berg, M. J., Leufkens, H. G. M., & van Solinge, W. W. (2009). Identification of exacerbations in obstructive lungdisease through biomarkers. Biomarkers, 14(7), 523-528.
Kars, M., Souverein, P. C., Herings, R. M. C., Romijn, J. A., Vandenbroucke, J. P., de Boer, A., & Dekkers, O. M. (2009). Estimated Age- and Sex-Specific Incidence and Prevalence of Dopamine Agonist-Treated Hyperprolactenemia. Journal of Clinical Endocrinology and Metabolism, 94(8), 2729-2734.
Other output
Rafi, S., Di Nisio, M., Porreca, E., De Boer, A., Souverein, P. C., Buller, H. R., & Kamphuisen, P. W. (2009). Nonsteroidal anti-inflammatory drugs increase the risk of pulmonary embolism. 206.
De Peuter, O. R., Souverein, P. C., Klungel, O. H., de Boer, A., Büller, H. R., & Kamphuisen, P. W. (2009). Non-Selective ß-Blockers Decrease Thrombotic Events in Patients with Heart Failure. Pharmacoepidemiology and Drug Safety, 18, S114.
Sino, C. G. M., Stuffken, R., Heerdink, E. R., Souverein, P. C., Schuurmans, M. J., & Egberts, A. C. G. (2009). Prescription Changes and Chronic Disease Score as Predictors for Hospitalization. Pharmacoepidemiology and Drug Safety, 18, S102.
Kröger, E., van Marum, R. J., Souverein, P. C., & Egberts, A. C. G. (2009). Factors Associated with Discontinuation of Cholinesterase Inhibitors in the Netherlands. Pharmacoepidemiology and Drug Safety, 18, S109.
Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., & de Vries, F. (2009). Use of Dopaminergic Drugs and Risk of Hip or Femur Fracture: A Population-Based Case-Control Study. Pharmacoepidemiology and Drug Safety, 18, S201.
2008
Scholarly publications
Knol, W., Van Marum, R. J., Jansen, P. A. F., Souverein, P. C., Schobben, A. F. A. M., & Egberts, A. C. G. (2008). Antipsychotic drug use and risk of pneumonia in elderly people. Journal of the American Geriatrics Society, 56(4), 661-666. [DOI]
Knol, M. J., Derijks, H. J., Geerlings, M. I., Heerdink, E. R., Souverein, P. C., Gorter, K. J., Grobbee, D. E., & Egberts, A. C. G. (2008). Influence of antidepressants on glycaemic control in patients with diabetes mellitus. Pharmacoepidemiology and Drug Safety, 17(6), 577-586.
Schalekamp, T., Klungel, O. H., Souverein, P. C., & de Boer, A. (2008). Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake inhibitors and Coumarins. Archives of Internal Medicine, 168(2), 180-185. [DOI] [Repository]
Schalekamp, T., Klungel, O. H., Souverein, P. C., & de Boer, A. (2008). Effect of oral antiplatelet agents on major bleeding in users of coumarins. Thrombosis and Haemostasis, 100(6), 1076-1083.
Wilting, I., Souverein, P. C., Nolen, W. A., Egberts, A. C. G., & Heerdink, E. R. (2008). Changes in outpatient lithium treatment in the Netherlands during 1996-2005. Journal of Affective Disorders, 111, 94-99.
Stuffken, R., Heerdink, E. R., De Koning, F. H. P., Souverein, P. C., & Egberts, A. C. G. (2008). Association Between Hospitalization and Discontinuity of Medication Therapy Used in the Community Setting in the Netherlands. Annals of Pharmacotherapy, 42, 933-939.
Layton, D., Souverein, P. C., Heerdink, E. R., Shakir, S. A., & Egberts, A. C. G. (2008). Prescriber adoption of newly approved selective COX-2 inhibitors. Pharmacoepidemiology and Drug Safety, 2008(17), 1168-1174.
Verdel, B. M., van Puijenbroek, E. P., Souverein, P. C., Leufkens, H. G. M., & Egberts, A. C. G. (2008). Drug-Related Nephrotoxic and Ototoxic Reactions: A Link through a Predictive Mechanistic Commonality. Drug Safety, 31(10), 877-884.
Layton, D., Souverein, P. C., Heerink, E. R., Shakir, S. A. W., & Egberts, A. C. G. (2008). Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users: A Cohort Study Using Pharmacy Dispensing Data in The Netherlands. Drug Safety, 31(2), 143-158. [Repository]
Knol, W., van Marum, R. J., Jansen, P. A. F., Souverein, P. C., Schobben, A. F. A. M., & Egberts, A. C. G. (2008). Antipsychotic Drug Use and Risk of Pneumonia in Eldery People. Journal of the American Geriatrics Society, 56(4), 661-666.
Professional publications
Verdel, B. M., van Puijenbroek, E. P., Souverein, P. C., Leufkens, H. G. M., & Egberts, A. C. G. (2008). Nier en binnenoor delen iontransportsysteem. Pharmaceutisch Weekblad, 23 mei(2008), 20-22. [Repository]
Other output
Layton, D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Shakir, S. A. W. (2008). Evaluating Prescriber Characteristics Associated with NSAID Prescribing Practices in the Netherlands. S66. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
van de Garde, E. M. W., Deneer, V. H. M., Souverein, P. C., van den Bosch, J. M. M., & Leufkens, H. G. M. (2008). Validation of Community-Acquired Pneumonia: High Postitive Predictive Value for ICD-9 Codes. S248. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Velthove, K. J., Bracke, M., Souverein, P. C., Schweizer, R. C., Leufkens, H. G. M., & van Solinge, W. W. (2008). Glucocorticoid Use Is Not Associated with Neutrophilia among Hospitalised Patients. S153. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Stolk, P., Souverein, P. C., Wilting, I., Leufkens, H. G. M., Klein, D. F., Rapoport, S. I., & Heerdink, E. R. (2008). Taking Low Dose Aspirin Is Associated with More Stable Drug Treatment for Lithium Users. S22. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Verdel, B. M., Souverein, P. C., Meyboom, R. H. B., Leufkens, H. G. M., & Egberts, A. C. G. (2008). Photochemical and Other Molecular Characteristics and the Risk of Drug-Related Photosensitivity. S113. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
2007
Scholarly publications
Gumbs, P. D., Verschuren, W. M. M., Souverein, P. C., Mantel-Teeuwisse, A. K., de Wit, G. A., de Boer, A., & Klungel, O. H. (2007). Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution. British Journal of Clinical Pharmacology, 64(5), 680-685. [DOI]
Handoko, K. B., Zwart-van Rijkom, J. E. F., Hermens, W. A. J. J., Souverein, P. C., & Egberts, A. C. G. (2007). Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study. Pharmacoepidemiology and Drug Safety, 16, 189-196. [Repository]
de Vries, F., Souverein, P. C., Cooper, C., Leufkens, H. G. M., & van Staa, T. P. (2007). Use of ß-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands. Calcified Tissue International, 80, 69-75. [DOI] [Repository]
van de Garde, E. M. W., Souverein, P. C., Hak, E., Deneer, V. H. M., van den Bosch, J. M. M., & Leufkens, H. G. M. (2007). Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes. Journal of Hypertension, 25(1), 235-239. [DOI] [Repository]
Stolk, P., Souverein, P. C., Leufkens, H. G. M., Weil, J. G., Egberts, A. C. G., & Heerdink, E. R. (2007). The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration. Pharmacopsychiatry, 40, 111-115. [Repository]
Other output
Verdel, B. M., van Puijenbroek, E. P., Souverein, P. C., Leufkens, H. G. M., & Egberts, A. C. G. (2007). Auricular and Renal Pharmacovigilance Data Are Linked Through a Predictive Mechanistic Commonality. S251. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Schalekamp, T., Klungel, O. H., Souverein, P. C., & de Boer, A. (2007). Effect of Oral Antiplatelet Drugs on Major Bleeding among Users of Coumarin Anticoagulants. S50. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Knol, M. J., Derijks, H. J., Geerlings, M. I., Heerdink, E. R., Souverein, P. C., Grobbee, D. E., & Egberts, A. C. G. (2007). Influence of Antidepressant Use on Insuline Need in Diabetes Mellitus Patients. S127. Abstract from Unknown event, Asilomar, USA.
Stuffken, R., Heerdink, E. R., Souverein, P. C., & Egberts, A. C. G. (2007). Hospitalisation as a Determinant for Discontinuity of Drug Use. P.014. Abstract from ISoP.
Velthove, K. J., Bracke, M., Schweizer, R. C., Souverein, P. C., ten Berg, M. J., Leufkens, H. G. M., & van Solinge, W. W. (2007). Neutrophilia Is Not Associated with Complications during Hospitalisation. S145. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Layton, D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Shakir, S. A. W. (2007). Nonsteroidal Anti-Inflammatory Drug (NSAID) Utilisation Factors in the Netherlands. P.029. Abstract from ISoP.
2006
Scholarly publications
ten Berg, M. J., Huisman, A., Souverein, P. C., Schobben, A. F. A. M., Egberts, A. C. G., van Solinge, W. W., & van den Bemt, P. M. L. A. (2006). Drug-Induced Thrombocytopenia. A Population Study. Drug Safety, 29(8), 713-721. [Repository]
Handoko, K. B., Souverein, P. C., van Staa, T. P., Meijboom, R. H. B., Leufkens, H. G. M., & Egberts, A. C. G. (2006). Risk of Aplastic Anemia in Patients Using Antiepileptic Drugs. Epilepsia, 47(7), 1232-1236. [Repository]
van de Garde, E. M. W., Souverein, P. C., van den Bosch, J. M. M., Deneer, V. H. M., & Leufkens, H. G. M. (2006). Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. European Respiratory Journal, 27(6), 1217-1222. [DOI]
van de Garde, E. M. W., Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M. M., & Leufkens, H. G. M. (2006). Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax, 61(11), 957-961. [Repository]
Verdel, B. M., Souverein, P. C., Egberts, A. C. G., & Leufkens, H. G. M. (2006). Difference in Risks of Allergic Reaction to Sulfonamide Drugs Based on Chemical Structure. Annals of Pharmacotherapy, 40, 1040-1046. [Repository]
Souverein, P. C., Webb, D. J., Weil, J. G., van Staa, T. P., & Egberts, A. C. G. (2006). Use of antiepileptic drugs and risk of fractures. Case-control study among patients with epilepsy. Neurology, 66, 1318-1324. [Repository]
Florentinus, S. R., Souverein, P. C., Griens, F. A. M. G., Groenewegen, P. P., Leufkens, B. G. M., & Heerdink, E. R. (2006). Linking community pharmacy dispensing data to prescribing data of general practitioners. BMC medical informatics and decision making [E], 6, Article 18. [DOI] [Repository]
van de Garde, E. M. W., Souverein, P. C., van den Bosch, J. M. M., Deneer, V. H. M., Goettsch, W. G., & Leufkens, H. G. M. (2006). Prior outpatient antibacterial therapy as prognostic factor for mortality in hospitalized pneumonia patients. Respiratory Medicine, 100(8), 1342-1348. [DOI]
Other output
van de Garde, E. M. W., Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M. M., & Leufkens, H. G. M. (2006). Statin Therapy and Reduced Risk of Pneumonia in Elderly Patients with Diabetes. S47. Abstract from Unknown event, Asilomar, USA.
Stolk, P., Souverein, P. C., Tatt, I. D., Egberts, A. C. G., Leufkens, H. G. M., Weil, J. G., & Heerdink, E. R. (2006). Do COX-2 Inhibitors Prevent Deterioration of Schizophrenia? A Nested Case-Control Study. S262. Abstract from Unknown event, Asilomar, USA.
Stuffken, R., Heerdink, E. R., de Koning, G. H. P., Souverein, P. C., & Egberts, A. C. G. (2006). Is Hospitalisation a Determinant for Discontinuity of Drug Use?. S101. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Speksnijder, N., van Staa, T. P., Olivier, B., Egberts, A. C. G., & Leufkens, H. G. M. (2006). Use of Oral Glucocorticoids and Risk of Suicide: A Cohort Study in the General Practice Research Database. S3. Abstract from Unknown event, Asilomar, USA.
ten Berg, M. J., Huisman, A., Souverein, P. C., Schobben, A. F. A. M., Egberts, A. C. G., van Solinge, W. W., & van den Bemt, P. M. L. A. (2006). In: Proceedings of the Dutch Society of Clinical Pharmacology and Biopharmacy meeting of October 4th 2005. Abstract from Unknown event, Asilomar, USA.
2005
Scholarly publications
De Vries, F., Souverein, PC., De Bruin, ML., Cooper, C., Van Staa, TP., & Leufkens, HGM. (2005). Use of beta-blockers and risk of hip and vertebral fractures: Associations with daily and cumulative dose. Bone, 36, S130-S130.
Souverein, P. C., Riemsdijk, M. M., de la Rosette, J. J. M. C. H., Opdam, P. C. E., & Leufkens, H. G. M. (2005). Treatment of Benign Prostatic Hyperplasia and Occurrence of Prostatic Surgery and Acute Urinary Retention: A Population-Based Cohort Study in The Netherlands. European Urology, 47, 505-510. [Repository]
Souverein, P. C., Webb, D. J., Petri, H., Weil, J., van Staa, T. P., & Egberts, A. C. G. (2005). Incidence of Fractures among Epilepsy Patients: A Population-based Retrospective Cohort Study in the General Practice Research Database. Epilepsia, 46(2), 304-310. [Repository]
Other output
van de Garde, E. M. W., van den Bosch, J. M. M., Deneer, V. H. M., Souverein, P. C., & Leufkens, H. G. M. (2005). Use of ACE-Inhibitors and Risk of Community-Acquired Pneumonia. S135. Abstract from Unknown event, Asilomar, USA.
Handoko, K. B., Zwart - van Rijkom, J. E. F., Hermens, W. A. J. J., Souverein, P. C., & Egberts, A. C. G. (2005). Changes in Medication in Relation to Epilepsy-Related Hospitalization: A Case Cross-Over Study. S55. Abstract from Unknown event, Asilomar, USA.
ten Berg, M. J., Huisman, A., Souverein, P. C., Schobben, A. F. A. M., Egberts, A. C. G., van Solinge, W. W., & van den Bemt, P. M. L. A. (2005). Drug-induced thrombocytopenia: a population-based case-control study. Abstract from Unknown event, Asilomar, USA.
van den Bemt, P. M. L. A., Souverein, P. C., van Staa, T. P., Meyboom, R. H. B., van Solinge, W. W., & Egberts, A. C. G. (2005). The Association between Antiepileptic Drug Use and Aplastic Anemia. S109. Abstract from Unknown event, Asilomar, USA.
Verdel, B. M., Souverein, P. C., Egberts, A. C. G., & Leufkens, H. G. M. (2005). Risk of Hypersensitivity Reactions and Allergic Events after Use of Sulfonamide Drugs in Patients with Diabetes Mellitus. S204. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Webb, D. J., Weil, J., van Staa, T. P., & Egberts, A. C. G. (2005). Use of Antiepileptic Drugs and Risk of Fractures: A Case-Control Study among Patients with Epilepsy. S192. Abstract from Unknown event, Asilomar, USA.
de Vries, F., Souverein, P. C., Leufkens, H. G. M., Cooper, C., van Staa, T. P., & de Bruin, M. L. (2005). Use of Beta-Blockers and Risk of Hip and Vertebral Fracture: Relationships to Daily and Cumulative Dose. S21. Abstract from Unknown event, Asilomar, USA.
2004
Scholarly publications
Souverein, P. C., Berard, A., van Staa, T. P., Cooper, C., Egberts, A. C. G., Leufkens, H. G. M., & Walker, B. R. (2004). Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart, 90, 859-865. [Repository]
Other output
Souverein, P. C., Webb, D. J., Petri, H. L., van Staa, T. P., & Egberts, A. C. G. (2004). Incidence of Fracatures among Epilepsy Patients: A Cohort Study in the General Practice Research Database. S94. Abstract from Unknown event, Asilomar, USA.
2003
Scholarly publications
Souverein, P. C., van Staa, T. P., Egberts, A. C. G., de la Rosette, J. J. M. C. H., & Cooper, C. (2003). Use of alpha-blockers and the risk of hip/femur fractures. Journal of Internal Medicine, 254, 548-554. [Repository]
Souverein, P. C., Erkens, J. A., de la Rosette, J. J. M. C. H., Leufkens, H. G. M., & Herings, R. M. C. (2003). Drug Treatment of Benign Prostatic Hyperplasia and Hospital Admission for BPH-Related Surgery. European Urology, 43, 528-534. [Repository]
Other output
Menckeberg, T. T., Bouvy, M. L., Bracke, M., Souverein, P. C., Belitser, S., Raaijmakers, J. A. M., & Leufkens, H. G. M. (2003). Patterns of Inhaled Corticosteroid Use in the Netherlands: A 10-year Follow-Up Study. S126. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Erkens, J. A., de la Rosette, J. J. M. C. H., Leufkens, H. G. M., & Herings, R. M. C. (2003). Increased Risk of Benign Prostatic Hyperplasia-Related Surgery in Patients Using Alpha-Blockers Compared to 5-Alpha Reductase Inhibitors. S133. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., de la Rosette, J. J. M. C. H., van Staa, T. P., Cooper, C., & Leufkens, H. G. M. (2003). Use of Alpha-Blockers and Risk of Hip/Femur Fractures. S152. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Berard, A., van Staa, T. P., Cooper, C., Egberts, A. C. G., Leufkens, H. G. M., & Walker, B. R. (2003). Use of Oral Glucocorticoids and Risk of Cardiovascular and Cerebrovascular Events. S56-S57. Abstract from Unknown event, Asilomar, USA.
2002
Scholarly publications
Souverein, P. C., Herings, R. M. C., Man in 't Veld, A. J., de la Rosette, J. J. M. C. H., Farmer, R. D. T., & Leufkens, H. G. M. (2002). Study of the Association between Ischemic Heart Disease and Use of Alpha-Blockers and Finasteride Indicated for the Treatment of Benign Prostatic Hyperplasia. European Urology, 42, 254-261.
Souverein, P. C. (2002). Drug effects in high-risk patients. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht].
Other output
Souverein, P. C., Egberts, A. C. G., meuleman, E. J. H., Urquhart, J., & Leufkens, H. G. M. (2002). Concomitant use of sildenafil and nitrates and risk of ischemic events. S141-S141. Abstract from Unknown event, Asilomar, USA.
2001
Scholarly publications
Souverein, P. C., Herings, R. M. C., de la Rosette, J. J. M. C. H., Man in 't Veld, AJ., Farmer, R. D. T., & Leufkens, H. G. M. (2001). Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia. Journal of Clinical Epidemiology, 54(5), 518-524. [Repository]
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., meuleman, E. J. H., & Leufkens, H. G. M. (2001). The Dutch cohort of sildenafil users: baseline characteristics. BJU International, 87, 648-653. [Repository]
Other output
Souverein, P. C., Herings, R. M. C., Man in 't Veld, A. J., de la Rosette, J. J. M. C. H., Farmer, R. D. T., & Leufkens, H. G. M. (2001). Study of the association between ischemic heart disease and the use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia. S79-S80. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., meuleman, E. J. H., Urquhart, J., & Leufkens, H. G. M. (2001). Determinants of sildenafil discontinuation in the Dutch cohort of sildenafil users. 231-231. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., meuleman, E. J. H., Urquhart, J., & Leufkens, H. G. M. (2001). The Dutch cohort of Sildenafil Users: baseline characteristics.. 219. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., meuleman, E. J. H., Leufkens, H. G. M., & Urquhart, J. (2001). Determinants of sildenafil discontinuation in the Dutch cohort of sildenafil users. S89-S90. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Herings, R. M. C., de la Rosette, J. J. M. C. H., Man in 't Veld, A. J., Farmer, R. D. T., & Leufkens, H. G. M. (2001). Geen associatie tussen ischemische hartziekten en gebruik van alfa blokkers en finasteride geindiceerd voor de behandeling van benigne prostaat hyperplasie. 46-46. Abstract from Unknown event, Asilomar, USA.
2000
Other output
Souverein, P. C., Herings, R. M. C., de la Rosette, J. J. M. C. H., Man in 't Veld, A. J., Farmer, R. D. T., & Leufkens, H. G. M. (2000). Evaluatie van cardiovasculaire bijwerkingen van geneesmiddelen bij de behandeling van benigne prostaat hyperplasie (BHP); methodologische overwegingen.. 46-46. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., & Leufkens, H. G. M. (2000). The Dutch cohort of sildenafil users - Baseline characteristics. S79-S79. Abstract from Unknown event, Asilomar, USA.